US20040220643A1 - Implantable medical device with rechargeable thin-film microbattery power source - Google Patents
Implantable medical device with rechargeable thin-film microbattery power source Download PDFInfo
- Publication number
- US20040220643A1 US20040220643A1 US10/855,832 US85583204A US2004220643A1 US 20040220643 A1 US20040220643 A1 US 20040220643A1 US 85583204 A US85583204 A US 85583204A US 2004220643 A1 US2004220643 A1 US 2004220643A1
- Authority
- US
- United States
- Prior art keywords
- circuit board
- substrate circuit
- electronics
- implantable medical
- battery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/378—Electrical supply
Definitions
- the invention relates to implantable medical devices having rechargeable thin-film microbattery power sources.
- the volatile component is a liquid electrolyte.
- it may also be a cathode material as in the lithium/iodine battery, or a combined electrolyte/cathode (“catholyte”), as in a lithium/thionyl chloride battery. In any case, leakage of these materials will cause catastrophic failure of the circuit or electronics of the device.
- the volatile components are contained by housing the active battery materials in a corrosion resistant metal case.
- the metal case is usually hermetically sealed either through a crimped seal with a polymer gasket, or by a welded seal.
- at least one electrical feedthrough also hermetic is required to access one electrode of the battery.
- the second electrode is often accessed by contact with the hermetic, metallic enclosure of the battery.
- the feedthrough is a relatively expensive component, requires extensive internal insulation, and is volumetrically inefficient.
- Both crimped-seal battery enclosures and welded battery enclosures require verification of hermetic seal integrity. With a crimped-seal battery, this is typically accomplished by storing the battery for a period of approximately 30 to 45 days, and then visually inspecting for signs of leakage (i.e., salt crystal formation or corrosion). This is a highly undesirable process due to the long manufacturing cycle time and the large delay between the initiation and detection of any issue with seal integrity.
- crimped-seal batteries typically require a circular shape that is difficult to package efficiently in an implantable medical device because of unused space at the “corners” when the circular shaped device is placed in the medical device and adjacent to the substrate circuit board upon which the electronics are located.
- Welded-seal batteries are typically subjected to a leak test procedure prior to filling with electrolyte, and then tested again after the final seal is welded in place.
- the first leak check is accomplished by pulling a vacuum on the welded battery case and cover through the electrolyte fill port while spraying helium on the exterior of the case. If helium leaks into the interior of the case, it is detected by a mass spectrometer.
- the second (final) leak check is more complicated. After the battery is filled with electrolyte (or cathode or catholyte) through a specially designed fill port, a temporary plug-type seal is placed deep in the fill port.
- the area above the temporary seal is either void volume or filled with a material that can absorb helium (e.g., very small porous glass spheres).
- a final seal is then welded in place at the entrance to the fill port, leaving a void volume or the helium absorbing material between the temporary seal and the final seal.
- the sealed battery is then placed in a helium atmosphere at a specified pressure for a specified time. If the final seal is not hermetic, helium will leak into the space between the two seals. The battery is then placed in an enclosure and a vacuum is pulled on the enclosure. If the final seal is not adequate, helium will leak from the fill port into the enclosure and be detected as described earlier.
- liquid electrolyte batteries have several added disadvantages that typically include the following: (1) a porous cathode filled with liquid electrolyte (which is volumetrically inefficient); (2) a porous or ion-conductive separator of sufficient dimension to prevent shorting by foreign particles (typically two layers of 0.001′′ or greater); (3) a large headspace for additional liquid electrolyte (porous cathodes often swell during discharge and require additional electrolyte to ensure that they remain immersed in liquid electrolyte); (4) a large headspace to allow for appropriate electrical insulation to provide isolation of positive and negative terminals of the battery and to provide thermal insulation to prevent damage to the active components during welding of the battery enclosure, which is typical for liquid electrolyte batteries; and (5) conductive diluents to make the cathode material electrically conductive and binders to hold cathode material together, which comprise about 10% to 15% by weight of the cathode.
- Crimped-seal and welded-seal batteries have several limitations with respect to geometry and physical dimensions. For example, crimped-seal designs are typically limited to circular shapes (a thin disk or cylinder). These shapes do not package efficiently in implantable devices and tend to result in a large amount of unusable volume. It also becomes very difficult to attain an adequate seal as the dimension of the seal area increases. Hence, it is difficult to build a thin, disk-shaped battery with a large diameter. Thin, large surface-area welded-seal batteries are also difficult to manufacture. Thinness is often limited by feedthrough dimensions, and surface area is limited by electrode handling properties and/or the tolerances of the case and cover materials.
- Welded-seal rechargeable batteries are typically prismatic, i.e., they are rectangular prism shaped batteries with 90 degree corners. A problem with such batteries is that they do not have a curved shape, which is desirable in an implantable medical device (except for the disadvantage of unused space as previously described above for circular shaped batteries when placed adjacent to a substrate circuit board within the device).
- FIG. 1A is a top cut-away view of a conventional implantable medical device 10 .
- Device 10 has a rechargeable battery 12 that is placed in a hermetic case 14 .
- Device 10 also has electronics 16 .
- Hermetic case 14 protects the electronics 16 from the liquid electrolyte (not shown) in rechargeable battery 12 .
- Device 10 also has a connector block 18 that is used to provide an electrical connection between device 10 and electrodes (not shown), which provide electrical stimulation to patient tissue.
- Device 10 has a shield 20 and a cover (not shown). As shown, battery 12 has straight sides 22 .
- FIG. 1B is a cross-sectional view of the conventional implantable medical device 10 taken along line B-B in FIG. 1A.
- FIG. 1C is a top cut-away view of a conventional implantable medical device 10 .
- Device 10 has a rechargeable circular battery 28 that is placed in a hermetic case 14 .
- Device 10 also has electronics 16 .
- Hermetic case 14 protects the electronics 16 from the liquid electrolyte (not shown) in rechargeable battery 28 .
- Device 10 also has a connector block 18 that is used to provide an electrical connection between device 10 and electrodes (not shown), which provide electrical stimulation to patient tissue.
- Device 10 has a shield 20 and a cover (not shown).
- battery 28 has a continuous curved side 30 .
- FIG. 1C is a cross-sectional view of the conventional implantable medical device 10 taken along line D-D in FIG. 1C.
- the present invention is an implantable medical device comprising an outer housing, electronics within the outer housing, the electronics located in on a substrate circuit board, and a rechargeable thin-film microbattery within the outer housing.
- the rechargeable thin-film microbattery of the present invention is a solid-state battery that is devoid of liquids or other volatile materials from which the electronics must be protected.
- the rechargeable thin-film microbattery has a straight first side that is adjacent to the substrate circuit board, and a curved second side that is adjacent to the outer housing.
- the rechargeable thin-film microbattery lies in a plane that is parallel to the substrate circuit board containing the electronics.
- the electronics are on a top side or first face of the substrate circuit board, and the rechargeable thin-film microbattery is positioned underneath a bottom side or second face of the substrate circuit board, the second face being on the side of the substrate circuit board opposite the first face.
- the rechargeable thin-film microbattery is deposited on the bottom side of the substrate circuit board.
- the rechargeable thin-film microbattery lies in a plan that is parallel to the substrate circuit board and the device includes a back-up battery adjacent to the circuit board and the rechargeable thin-film microbattery.
- a first group of the electronics is located on a first face of the substrate circuit board, and a second group of electronics is located on a second face of the electronics are located on the bottom side of the substrate circuit board, and the rechargeable thin-film microbattery is located underneath or over a back-up battery, and both batteries are located adjacent to the substrate circuit board.
- the rechargeable thin-film microbattery lies in a plane that is parallel to the substrate circuit board, the electronics are located on the a first face or the first face and the second face of the substrate circuit board, and the microbattery is positioned adjacent the second face of the substrate circuit board and is adjacent to at least a portion of a back-up battery that is adjacent to the substrate circuit board.
- FIG. 1A is a top cut-away view of a conventional implantable medical device having a prismatic battery containing a liquid electrolyte.
- FIG. 1B is a cross-sectional view of the conventional implantable medical device shown in FIG. 1A taken along line B-B.
- FIG. 1C is a top cut-away view of a conventional implantable medical device having a circular battery containing a liquid electrolyte.
- FIG. 1D is a cross-sectional view of the conventional implantable medical device shown in FIG. 1C taken along line D-D.
- FIG. 2A is a top cut-away view of a preferred embodiment of the implantable medical device of the present invention.
- FIG. 2B is a cross-sectional view of a preferred embodiment of the implantable medical device of the present invention shown in FIG. 2A taken along line B-B.
- FIG. 3A is a top cut-away view of a preferred embodiment of the implantable medical device of the present invention.
- FIG. 3B is a cross-sectional view of a preferred embodiment of the implantable medical device of the present invention shown in FIG. 3A taken along line B-B.
- FIG. 3C is a cross-sectional view of an alternative preferred embodiment of the implantable medical device of the present invention shown in FIG. 3A taken along line B-B.
- FIG. 3E is a cross-sectional view of another alternative preferred embodiment of the implantable medical device of the present invention shown in FIG. 3A taken along line B-B.
- FIG. 4B is a cross-sectional view of an alternative preferred embodiment of the implantable medical device of the present invention shown in FIG. 4A taken along line B-B.
- FIG. 5A is a top cut-away view of an alternative preferred embodiment of the implantable medical device of the present invention.
- FIG. 6A is a cross-sectional view of stacked microbatteries in a series configuration in accordance with the present invention.
- FIG. 6B is a cross-sectional view of stacked microbatteries in a parallel configuration in accordance with the present invention.
- FIG. 6C is a cross-sectional view of stacked microbatteries in a dynamically reconfigureable arrangement.
- FIGS. 2A and 2B illustrate a preferred embodiment of the present invention.
- an implantable medical device 50 comprises an outer housing 52 , electronics 54 within the outer housing 52 , the electronics 54 located on a substrate circuit board 56 , and a rechargeable thin-film microbattery 58 within the outer housing 52 .
- the rechargeable thin-film microbattery 58 of the present invention is a solid-state battery that is devoid of liquids or other volatile materials from which the electronics must be protected.
- the rechargeable thin-film microbattery 58 has a straight first side 60 that is adjacent to the substrate circuit board 56 , and a curved second side 62 that is adjacent to the outer housing 52 .
- the rechargeable thin-film battery 58 has a “D” shape. This “D” shape retains the curved outer edge desirable for an implantable medical device (which is not achieved with a conventional device having a liquid electrolyte, prismatic battery shown in FIGS. 1A and 1B), while at the same time, avoids unused space resulting from using a circular battery in a conventional device (shown in FIGS. 1C and 1D).
- Device 50 also has a connector block 59 that is used to provide an electrical connection between device 50 and electrodes (not shown), which provide electrical stimulation to patient tissue.
- Device 50 has a cover (not shown) for the outer housing 52 .
- Device 50 also has a coil of wire for charging the battery 58 via induction. The coil (not shown), can be located either internal or external to device 50 .
- the rechargeable thin-film battery 58 in device 50 is a solid-state battery, no separator is required to provide a physical barrier between the anode and the cathode (not shown) in battery 58 to account for the presence of a liquid electrolyte.
- the rechargeable thin-film battery 58 in device 50 is a solid-state battery, there is no need for a hermetic seal to protect the electronics 54 from a liquid electrolyte, as is required in conventional medical devices.
- the present invention provides a medical device with a desired shape and less unused space.
- FIG. 2B is a cross-sectional view of the conventional implantable medical device 50 shown in FIG. 1A.
- FIGS. 3A and 3B An alternative embodiment is shown in FIGS. 3A and 3B.
- the embodiment shown in FIGS. 3A and 3B illustrates a device 70 , a rechargeable thin-film microbattery 72 , and a primary or back-up battery 74 .
- Microbattery 72 is positioned underneath substrate circuit board 56 .
- Microbattery 72 can be deposited onto substrate circuit board 56 if desired.
- Backup battery 74 can be rechargeable if desired.
- Back-up battery 74 can be made in the same manner as microbattery 72 .
- back-up battery 74 can be a non-rechargeable battery and easily packaged as a lower power source. As shown in FIG.
- back-up battery 74 can have a straight side 76 adjacent to the substrate circuit board 56 and the microbattery 72 . As further shown in FIGS. 3A and 3B, back-up battery 74 can have a curved side 78 adjacent to the outer housing 52 .
- Device 70 further has electronics 54 on substrate circuit board 56 , and a connector block 59 as previously described.
- Back-up battery 74 may be particularly desirable in a medical device that is used for life support of a patient. If desired, back-up battery 74 can serve as a power source for a particular electrical requirement, e.g., for electrical stimulation to the patient, and microbattery 72 can serve as a power source for a different particular electrical requirement.
- FIG. 3C Another embodiment of the present invention is shown for device 80 in FIG. 3C.
- the embodiment shown in FIG. 3C is similar to the embodiment shown in FIG. 3B, except microbattery 72 is positioned underneath back-up battery 74 .
- Microbattery 72 can have a straight side 60 adjacent to substrate circuit board 56
- back-up battery 74 can have a straight side 76 adjacent to substrate circuit board 56 .
- Microbattery 72 can have a curved side 62 adjacent to outer housing 52
- back-up battery 74 can have a curved side 78 adjacent outer housing 52 .
- electronics 54 are positioned above and below substrate circuit board 56 .
- FIG. 3D Another embodiment of the present invention is shown for device 90 in FIG. 3D.
- the embodiment shown in FIG. 3D is similar to the embodiments shown in FIGS. 3B and 3C, except microbattery 72 is positioned underneath back-up battery 74 and substrate circuit board 56 .
- Microbattery 72 can have a straight side 92 at a first end 94 of the microbattery and adjacent to substrate circuit board 56 .
- Back-up battery 74 can have a straight side 76 adjacent to substrate circuit board 56 .
- Microbattery 72 can have a curved side 62 adjacent to outer housing 52 at a second end 96 of microbattery 72 .
- Back-up battery 74 can have a curved side 78 adjacent outer housing 52 .
- electronics 54 are positioned above substrate circuit board 56 .
- FIG. 3E Another embodiment of the present invention is shown for device 97 in FIG. 3E.
- the embodiment shown in FIG. 3E is similar to the embodiments shown in FIGS. 3B, 3C, and 3 D, except microbattery 72 is positioned underneath back-up battery 74 and substrate circuit board 56 , and electronics 54 are positioned both above and below substrate circuit board 56 . Additional portion 99 for microbattery 72 is shown underneath back-up battery 74 since there are no electronics 54 at this location in the device 97 . Alternatively, a corresponding portion (not shown) can be added to back-up battery 74 instead of additional portion 99 for microbattery 72 .
- Microbattery 72 can have a straight side 92 at a first end 94 of microbattery 72 and adjacent to substrate circuit board 56 .
- Back-up battery 74 can have a straight side 76 adjacent to substrate circuit board 56 .
- Microbattery 72 can have a curved side 62 adjacent to outer housing 52 at a second end 96 of microbattery 72 .
- Back-up battery 74 can have a curved side 78 adjacent outer housing 52 .
- electronics 54 are positioned above and below substrate circuit board 56 .
- FIGS. 4A and 4B Another embodiment of the present invention is shown in FIGS. 4A and 4B.
- a device 100 has an outer housing 102 , a substrate circuit board 106 , and electronics 104 on the substrate circuit board.
- Device 100 further has a rechargeable thin-film microbattery 108 underneath substrate circuit board 106 .
- the substrate circuit board 106 and the microbattery 108 are oval in shape.
- Microbattery 108 can have a curved side 110
- substrate circuit board 106 can have a curved side 112 , which are shown in FIGS. 4A and 4B.
- Device 100 can have a connector block 109 that serves the same function and purpose as connector block 59 in FIGS. 2A, 2B, 3 A, 3 B, 3 C, 3 D, and 3 E.
- FIG. 4B is a cross-sectional view of device 100 taken along line B-B in FIG. 4A.
- FIG. 5 Another embodiment of the present invention is shown in FIG. 5.
- the device 120 shown in FIG. 5 is the same as the device 50 shown in FIGS. 2A and 2B, except that instead of a single microbattery 58 , the device now has two or more microbatteries that are stacked. As shown in FIG. 5, device 120 has three microbatteries 130 , 132 , and 134 that are stacked.
- the stacked microbatteries 130 , 132 , 134 can be connected in either a series configuration 140 (shown in FIG. 6A) or a parallel configuration 142 (shown in FIG. 6B).
- This flexibility in configuration of stacked microbatteries is an additional advantage of the present invention over the conventional device.
- Arrangement 144 can be used to create a series connection, a parallel connection, or combination of series and parallel connections between the individual microbatteries.
- the result is a battery configuration that can comprise a variety of voltage and capacity combinations. For example, three 4 volt microbatteries can be configured in a parallel configuration for charging, and then reconfigured in a series configuration via device programming to create a 12 volt microbattery for discharge, or vice-a-versa.
- the ability to dynamically create a higher voltage battery is an advantage when the voltage at the stimulation site is greater than the voltage of that of a single cell (i.e., 4 volts in the example above).
- this multiplication of battery voltage is typically achieved by dynamically reconfigureable capacitors.
- the capacitors are charged in parallel to the voltage of the single cell battery, and then are reconfigured in series to create the desired stimulation voltage.
- the dynamically reconfigureable battery of the present invention eliminates the capacitor components required for reconfiguration, thereby creating a simpler, and more volumetrically efficient device.
- the rechargeable thin-film microbattery lies in a plane that is parallel to the substrate circuit board containing the electronics.
- the electronics are on a top side of the substrate circuit board, and the rechargeable thin-film microbattery is positioned underneath a bottom side of the substrate circuit board.
- the rechargeable thin-film microbattery is deposited on the bottom side of the substrate circuit board.
- the rechargeable thin-film microbattery lies in a plan that is parallel to the substrate circuit board and the device includes a back-up battery adjacent to the circuit board and the rechargeable thin-film microbattery.
- some of the electronics are located on the top side of the substrate circuit board, and some of the electronics are located on the bottom side of the substrate circuit board, and the rechargeable thin-film microbattery is located underneath or over the back-up battery, and both batteries are located adjacent to the substrate circuit board.
- the rechargeable thin-film microbattery lies in a plane that is parallel to the substrate circuit board, and the microbattery is positioned underneath a bottom side of the substrate circuit board and is underneath at least a portion of a back-up battery that is adjacent to the substrate circuit board.
- the present invention provides many advantages over current implantable medical devices, including but not limited to: (1) an implantable medical device with a power source devoid of volatile components; (2) an implantable medical device with a power source that does not require an independent, hermetic compartment within the an implantable medical device to separate the power source from other components of the device; (3) increased design flexibility since the power source of the implantable medical device can be configured in a wide variety of shapes, including thin film shapes that can overlay other components of the implantable medical device, such as a microprocessor and/or electronic circuitry; (4) an implantable medical device with greater volumetric efficiency (that is, more electrical power without increasing the size of the implantable medical device); (5) simpler manufacturing steps to make an implantable medical device; (6) elimination of electrical feedthroughs between the power source and the electronics; and (7) elimination of need to check against leaks of battery liquids (that is, verification of seal integrity).
- the thin-film battery of the present invention can be made in accordance with methods taught in U.S. Pat. Nos. 5,338,625, 5,561,004, and 6,168,884 (all of which are incorporated herein by reference).
- the thin-film battery may incorporate a protective coating to protect the power source from ambient conditions (particularly moisture) prior to assembly of the power source into the implantable medical device.
- a protective coating to protect the power source from ambient conditions (particularly moisture) prior to assembly of the power source into the implantable medical device.
- a coating is described in U.S. Pat. No. 5,561,004 (which is incorporated herein by reference).
- coatings such as this are not hermetic and are intended merely to provide a temporary protection of the battery materials from the atmosphere, not protection of the electronics from the battery materials.
- Alternate forms of the thin film battery that do not contain metallic lithium prior to the first charge of the battery may not require a protective coating (e.g., the battery disclosed in U.S. Pat. No. 6,168,884).
- the implantable medical devices of the present invention provide the following advantages over typical implantable medical devices with respect to volumetric efficiency: (1) no separator is required—the thin layer of solid-state electrolyte provides the separator function; (2) no conductive diluents or binders are required—the cathode is 100% active; (3) there is no need for “excess” liquid electrolyte to cover the cathode and the anode; (4) no electrical feed throughs are required between the thin-film battery and the electronics; and (5) there is no separate battery case since the battery can be deposited on a thin substrate.
- the implantable medical device of the present invention provides the following advantages over typical implantable medical devices with respect to packaging: (1) the design shape of the power source is not limited to circular shapes (such as a thin disk or cylinder), which is a shape that does not package efficiently in implantable medical devices and tend to result in a large amount of unusable volume within the device; (2) there is no need to achieve an adequate seal as the dimension of the seal area increases, and thus it is easier to build a thin-film battery with a large surface area; and (3) the thinness of the power source is not as limited by feedthrough dimensions, electrode handling properties or tolerances of the case and cover materials as the prior art devices.
- the thin-film batteries of the present invention provide the certain advantages with respect to thinness and efficient packaging.
- active materials are deposited on a thin substrate that can be large in surface area. In some cases, a limited degree of substrate flexibility may also be possible. When larger capacities are required, it may be possible to deposit several layers of active materials or stack and interconnect several cells, each deposited on its own substrate. The deposit of several layers of active materials may be accomplished in accordance with the methods disclosed in U.S. Pat. No. 5,569,520, which is incorporated herein by reference.
- the substrate has essentially unlimited shape flexibility, thereby allowing the battery to fit efficiently into the shape of the implanted device.
- smaller medical devices can be designed so that they can be placed within a human being closer to a target site than are possible with current medical devices. By placing the medical device closer to the target site, less problems in transfer of electrical stimulation therapy are encountered.
- smaller medical devices can be designed so that they can be placed within a human being at a location that will be less noticeable or not noticeable by a viewer looking at the human who has the implanted medical device.
- the thinness of battery and substrate in accordance with the present invention allows the battery to be stacked with other components.
- the rechargeable thin-film battery of the present invention may be stacked with a back-up battery, stacked with the circuit, or located across the entire shield of the implanted device (i.e., stacked with all components).
- the active materials can be placed directly onto the same substrate as the circuit components.
- a substrate can be populated by circuit components on one side of the substrate, and by active battery materials on the other side of the substrate.
- the present invention also provides advantages over current implantable medical devices with respect to the charging coil.
- rechargeable batteries in implantable medical devices involve recharging by induction. This requires incorporation of a secondary coil in the implanted medical device.
- the coil is a discrete component that is wound from wire and located either internal to the device or encased in polymer and located on an external surface of the device.
- the present invention also provides manufacturing advantages over the manufacturing methods of conventional implantable medical devices. More specifically, the fabrication of the battery and device can be more easily automated and justified for smaller volumes. As previously noted, the batteries can be fabricated on the same substrate as the circuit. Further, the battery can be exposed to solder-reflow conditions without damage. See U.S. Pat. No. 6,168,884, which is incorporated herein by reference.
- the implantable medical device of the present invention provides the following further advantages over conventional devices: (1) nearly unlimited cycle life—Charge/discharge cycles in excess of 50,000 have been demonstrated; (2) little or no time-dependent capacity loss; and (3) no “memory effect.”
Abstract
The present invention is an implantable medical device comprising an outer housing, electronics within the outer housing, the electronics located in on a substrate circuit board, and a rechargeable thin-film microbattery within the outer housing. The rechargeable thin-film microbattery of the present invention is a solid-state battery that is devoid of liquids or other volatile materials from which the electronics must be protected. In one embodiment, the rechargeable thin-film microbattery has a straight first side that is adjacent to the substrate circuit board, and a curved second side that is adjacent to the outer housing. In one embodiment, the rechargeable thin-film microbattery lies in a plane that is parallel to the substrate circuit board containing the electronics. In one embodiment, the electronics are on a first face of the substrate circuit board, and the rechargeable thin-film microbattery is positioned adjacent a second face of the substrate circuit board, the second face being on the side of the substrate circuit board opposite to the first face. In one embodiment, the rechargeable thin-film microbattery is deposited on the bottom face of the substrate circuit board. In one embodiment, the may be two or more microbatteries that are stacked in series or in parallel.
Description
- This is a divisional application of U.S. Ser. No. 09/843,673 filed Apr. 27, 2001, which is incorporated herein by reference in its entirety.
- The invention relates to implantable medical devices having rechargeable thin-film microbattery power sources.
- Current implantable medical devices require an electrical power source that contains one or more volatile components. These volatile components must be effectively contained in the battery throughout the life of the medical device. Typically, the volatile component is a liquid electrolyte. However, it may also be a cathode material as in the lithium/iodine battery, or a combined electrolyte/cathode (“catholyte”), as in a lithium/thionyl chloride battery. In any case, leakage of these materials will cause catastrophic failure of the circuit or electronics of the device.
- Typically, the volatile components are contained by housing the active battery materials in a corrosion resistant metal case. The metal case is usually hermetically sealed either through a crimped seal with a polymer gasket, or by a welded seal. In the latter case, at least one electrical feedthrough (also hermetic) is required to access one electrode of the battery. The second electrode is often accessed by contact with the hermetic, metallic enclosure of the battery. The feedthrough is a relatively expensive component, requires extensive internal insulation, and is volumetrically inefficient.
- Both crimped-seal battery enclosures and welded battery enclosures require verification of hermetic seal integrity. With a crimped-seal battery, this is typically accomplished by storing the battery for a period of approximately 30 to 45 days, and then visually inspecting for signs of leakage (i.e., salt crystal formation or corrosion). This is a highly undesirable process due to the long manufacturing cycle time and the large delay between the initiation and detection of any issue with seal integrity. In addition to the need for and difficulty in verifying the integrity of the seal, crimped-seal batteries typically require a circular shape that is difficult to package efficiently in an implantable medical device because of unused space at the “corners” when the circular shaped device is placed in the medical device and adjacent to the substrate circuit board upon which the electronics are located.
- Welded-seal batteries are typically subjected to a leak test procedure prior to filling with electrolyte, and then tested again after the final seal is welded in place. The first leak check is accomplished by pulling a vacuum on the welded battery case and cover through the electrolyte fill port while spraying helium on the exterior of the case. If helium leaks into the interior of the case, it is detected by a mass spectrometer. The second (final) leak check is more complicated. After the battery is filled with electrolyte (or cathode or catholyte) through a specially designed fill port, a temporary plug-type seal is placed deep in the fill port. The area above the temporary seal is either void volume or filled with a material that can absorb helium (e.g., very small porous glass spheres). A final seal is then welded in place at the entrance to the fill port, leaving a void volume or the helium absorbing material between the temporary seal and the final seal. The sealed battery is then placed in a helium atmosphere at a specified pressure for a specified time. If the final seal is not hermetic, helium will leak into the space between the two seals. The battery is then placed in an enclosure and a vacuum is pulled on the enclosure. If the final seal is not adequate, helium will leak from the fill port into the enclosure and be detected as described earlier.
- Furthermore, liquid electrolyte batteries, have several added disadvantages that typically include the following: (1) a porous cathode filled with liquid electrolyte (which is volumetrically inefficient); (2) a porous or ion-conductive separator of sufficient dimension to prevent shorting by foreign particles (typically two layers of 0.001″ or greater); (3) a large headspace for additional liquid electrolyte (porous cathodes often swell during discharge and require additional electrolyte to ensure that they remain immersed in liquid electrolyte); (4) a large headspace to allow for appropriate electrical insulation to provide isolation of positive and negative terminals of the battery and to provide thermal insulation to prevent damage to the active components during welding of the battery enclosure, which is typical for liquid electrolyte batteries; and (5) conductive diluents to make the cathode material electrically conductive and binders to hold cathode material together, which comprise about 10% to 15% by weight of the cathode.
- Crimped-seal and welded-seal batteries have several limitations with respect to geometry and physical dimensions. For example, crimped-seal designs are typically limited to circular shapes (a thin disk or cylinder). These shapes do not package efficiently in implantable devices and tend to result in a large amount of unusable volume. It also becomes very difficult to attain an adequate seal as the dimension of the seal area increases. Hence, it is difficult to build a thin, disk-shaped battery with a large diameter. Thin, large surface-area welded-seal batteries are also difficult to manufacture. Thinness is often limited by feedthrough dimensions, and surface area is limited by electrode handling properties and/or the tolerances of the case and cover materials.
- Welded-seal rechargeable batteries are typically prismatic, i.e., they are rectangular prism shaped batteries with 90 degree corners. A problem with such batteries is that they do not have a curved shape, which is desirable in an implantable medical device (except for the disadvantage of unused space as previously described above for circular shaped batteries when placed adjacent to a substrate circuit board within the device).
- An example of a conventional implantable medical device having a prismatic battery having a liquid electrolyte is shown in FIGS. 1A and 1B. Referring to the drawings, FIG. 1A is a top cut-away view of a conventional implantable
medical device 10.Device 10 has arechargeable battery 12 that is placed in ahermetic case 14.Device 10 also haselectronics 16.Hermetic case 14 protects theelectronics 16 from the liquid electrolyte (not shown) inrechargeable battery 12.Device 10 also has aconnector block 18 that is used to provide an electrical connection betweendevice 10 and electrodes (not shown), which provide electrical stimulation to patient tissue.Device 10 has ashield 20 and a cover (not shown). As shown,battery 12 hasstraight sides 22.Separator 24 is used to provide a physical barrier that is needed between the anode and the cathode (not shown) inbattery 12 since it has a liquid electrolyte.Electronics 16 are located on asubstrate circuit board 26.Device 10 also has a coil of wire for charging thebattery 12 via induction. The coil (not shown), can be located either internal or external todevice 10. FIG. 1B is a cross-sectional view of the conventional implantablemedical device 10 taken along line B-B in FIG. 1A. - An example of a conventional implantable medical device having a circular battery with a liquid electrolyte is shown in FIGS. 1C and 1D. Referring to the drawings, FIG. 1C is a top cut-away view of a conventional implantable
medical device 10.Device 10 has a rechargeablecircular battery 28 that is placed in ahermetic case 14.Device 10 also haselectronics 16.Hermetic case 14 protects theelectronics 16 from the liquid electrolyte (not shown) inrechargeable battery 28.Device 10 also has aconnector block 18 that is used to provide an electrical connection betweendevice 10 and electrodes (not shown), which provide electrical stimulation to patient tissue.Device 10 has ashield 20 and a cover (not shown). As shown,battery 28 has a continuouscurved side 30.Separator 34 is used to provide a physical barrier that is needed between the anode and the cathode (not shown) inbattery 28 since it has a liquid electrolyte. As shown in FIG. 1C,unused space 32 exists because thebattery 28 having acircular side 30 does not fill reach theunused space 32 defined by thebattery 28,shield 20 andsubstrate circuit board 26.Unused space 32 is one of the important disadvantages in this conventional device.Electronics 16 are located on asubstrate circuit board 26.Device 10 also has a coil of wire for charging thebattery 28 via induction. The coil (not shown), can be located either internal or external todevice 10. FIG. 1D is a cross-sectional view of the conventional implantablemedical device 10 taken along line D-D in FIG. 1C. - The present invention is an implantable medical device comprising an outer housing, electronics within the outer housing, the electronics located in on a substrate circuit board, and a rechargeable thin-film microbattery within the outer housing. The rechargeable thin-film microbattery of the present invention is a solid-state battery that is devoid of liquids or other volatile materials from which the electronics must be protected.
- In a preferred embodiment, the rechargeable thin-film microbattery has a straight first side that is adjacent to the substrate circuit board, and a curved second side that is adjacent to the outer housing.
- In a preferred embodiment, the rechargeable thin-film microbattery lies in a plane that is parallel to the substrate circuit board containing the electronics. In a preferred embodiment, the electronics are on a top side or first face of the substrate circuit board, and the rechargeable thin-film microbattery is positioned underneath a bottom side or second face of the substrate circuit board, the second face being on the side of the substrate circuit board opposite the first face. In a further preferred embodiment, the rechargeable thin-film microbattery is deposited on the bottom side of the substrate circuit board.
- In another preferred embodiment, the rechargeable thin-film microbattery lies in a plan that is parallel to the substrate circuit board and the device includes a back-up battery adjacent to the circuit board and the rechargeable thin-film microbattery.
- In an alternative preferred embodiment, a first group of the electronics is located on a first face of the substrate circuit board, and a second group of electronics is located on a second face of the electronics are located on the bottom side of the substrate circuit board, and the rechargeable thin-film microbattery is located underneath or over a back-up battery, and both batteries are located adjacent to the substrate circuit board.
- In an alternative preferred embodiment, the rechargeable thin-film microbattery lies in a plane that is parallel to the substrate circuit board, the electronics are located on the a first face or the first face and the second face of the substrate circuit board, and the microbattery is positioned adjacent the second face of the substrate circuit board and is adjacent to at least a portion of a back-up battery that is adjacent to the substrate circuit board.
- FIG. 1A is a top cut-away view of a conventional implantable medical device having a prismatic battery containing a liquid electrolyte.
- FIG. 1B is a cross-sectional view of the conventional implantable medical device shown in FIG. 1A taken along line B-B.
- FIG. 1C is a top cut-away view of a conventional implantable medical device having a circular battery containing a liquid electrolyte.
- FIG. 1D is a cross-sectional view of the conventional implantable medical device shown in FIG. 1C taken along line D-D.
- FIG. 2A is a top cut-away view of a preferred embodiment of the implantable medical device of the present invention.
- FIG. 2B is a cross-sectional view of a preferred embodiment of the implantable medical device of the present invention shown in FIG. 2A taken along line B-B.
- FIG. 3A is a top cut-away view of a preferred embodiment of the implantable medical device of the present invention.
- FIG. 3B is a cross-sectional view of a preferred embodiment of the implantable medical device of the present invention shown in FIG. 3A taken along line B-B.
- FIG. 3C is a cross-sectional view of an alternative preferred embodiment of the implantable medical device of the present invention shown in FIG. 3A taken along line B-B.
- FIG. 3D is a cross-sectional view of another alternative preferred embodiment of the implantable medical device of the present invention shown in FIG. 3A taken along line B-B.
- FIG. 3E is a cross-sectional view of another alternative preferred embodiment of the implantable medical device of the present invention shown in FIG. 3A taken along line B-B.
- FIG. 4A is a top cut-away view of an alternative preferred embodiment of the implantable medical device of the present invention.
- FIG. 4B is a cross-sectional view of an alternative preferred embodiment of the implantable medical device of the present invention shown in FIG. 4A taken along line B-B.
- FIG. 5A is a top cut-away view of an alternative preferred embodiment of the implantable medical device of the present invention.
- FIG. 5B is a cross-sectional view of an alternative preferred embodiment of the implantable medical device of the present invention shown in FIG. 5A taken along line B-B.
- FIG. 6A is a cross-sectional view of stacked microbatteries in a series configuration in accordance with the present invention.
- FIG. 6B is a cross-sectional view of stacked microbatteries in a parallel configuration in accordance with the present invention.
- FIG. 6C is a cross-sectional view of stacked microbatteries in a dynamically reconfigureable arrangement.
- FIGS. 2A and 2B illustrate a preferred embodiment of the present invention. As shown, an implantable
medical device 50 comprises anouter housing 52,electronics 54 within theouter housing 52, theelectronics 54 located on asubstrate circuit board 56, and a rechargeable thin-film microbattery 58 within theouter housing 52. The rechargeable thin-film microbattery 58 of the present invention is a solid-state battery that is devoid of liquids or other volatile materials from which the electronics must be protected. - In the embodiment shown in FIGS. 2A and 2B, the rechargeable thin-
film microbattery 58 has a straightfirst side 60 that is adjacent to thesubstrate circuit board 56, and a curvedsecond side 62 that is adjacent to theouter housing 52. As shown in FIGS. 2A and 2B, the rechargeable thin-film battery 58 has a “D” shape. This “D” shape retains the curved outer edge desirable for an implantable medical device (which is not achieved with a conventional device having a liquid electrolyte, prismatic battery shown in FIGS. 1A and 1B), while at the same time, avoids unused space resulting from using a circular battery in a conventional device (shown in FIGS. 1C and 1D).Device 50 also has aconnector block 59 that is used to provide an electrical connection betweendevice 50 and electrodes (not shown), which provide electrical stimulation to patient tissue.Device 50 has a cover (not shown) for theouter housing 52.Device 50 also has a coil of wire for charging thebattery 58 via induction. The coil (not shown), can be located either internal or external todevice 50. - Since the rechargeable thin-
film battery 58 indevice 50 is a solid-state battery, no separator is required to provide a physical barrier between the anode and the cathode (not shown) inbattery 58 to account for the presence of a liquid electrolyte. In addition, since the rechargeable thin-film battery 58 indevice 50 is a solid-state battery, there is no need for a hermetic seal to protect theelectronics 54 from a liquid electrolyte, as is required in conventional medical devices. By removing the need for a separator and a hermetic seal, the present invention provides a medical device with a desired shape and less unused space. - In the embodiment shown in FIG. 2B,
electronics 54 are located on both sides ofsubstrate circuit board 56. FIG. 2B is a cross-sectional view of the conventional implantablemedical device 50 shown in FIG. 1A. - An alternative embodiment is shown in FIGS. 3A and 3B. The embodiment shown in FIGS. 3A and 3B illustrates a
device 70, a rechargeable thin-film microbattery 72, and a primary or back-upbattery 74.Microbattery 72 is positioned underneathsubstrate circuit board 56.Microbattery 72 can be deposited ontosubstrate circuit board 56 if desired.Backup battery 74 can be rechargeable if desired. Back-upbattery 74 can be made in the same manner asmicrobattery 72. Alternatively back-upbattery 74 can be a non-rechargeable battery and easily packaged as a lower power source. As shown in FIG. 3B, back-upbattery 74 can have astraight side 76 adjacent to thesubstrate circuit board 56 and themicrobattery 72. As further shown in FIGS. 3A and 3B, back-upbattery 74 can have acurved side 78 adjacent to theouter housing 52.Device 70 further haselectronics 54 onsubstrate circuit board 56, and aconnector block 59 as previously described. Back-upbattery 74 may be particularly desirable in a medical device that is used for life support of a patient. If desired, back-upbattery 74 can serve as a power source for a particular electrical requirement, e.g., for electrical stimulation to the patient, andmicrobattery 72 can serve as a power source for a different particular electrical requirement. - Another embodiment of the present invention is shown for
device 80 in FIG. 3C. The embodiment shown in FIG. 3C is similar to the embodiment shown in FIG. 3B, exceptmicrobattery 72 is positioned underneath back-upbattery 74.Microbattery 72 can have astraight side 60 adjacent tosubstrate circuit board 56, and back-upbattery 74 can have astraight side 76 adjacent tosubstrate circuit board 56.Microbattery 72 can have acurved side 62 adjacent toouter housing 52, and back-upbattery 74 can have acurved side 78 adjacentouter housing 52. In FIG. 3C,electronics 54 are positioned above and belowsubstrate circuit board 56. - Another embodiment of the present invention is shown for
device 90 in FIG. 3D. The embodiment shown in FIG. 3D is similar to the embodiments shown in FIGS. 3B and 3C, exceptmicrobattery 72 is positioned underneath back-upbattery 74 andsubstrate circuit board 56.Microbattery 72 can have astraight side 92 at afirst end 94 of the microbattery and adjacent tosubstrate circuit board 56. Back-upbattery 74 can have astraight side 76 adjacent tosubstrate circuit board 56.Microbattery 72 can have acurved side 62 adjacent toouter housing 52 at asecond end 96 ofmicrobattery 72. Back-upbattery 74 can have acurved side 78 adjacentouter housing 52. In FIG. 3D,electronics 54 are positioned abovesubstrate circuit board 56. - Another embodiment of the present invention is shown for
device 97 in FIG. 3E. The embodiment shown in FIG. 3E is similar to the embodiments shown in FIGS. 3B, 3C, and 3D, exceptmicrobattery 72 is positioned underneath back-upbattery 74 andsubstrate circuit board 56, andelectronics 54 are positioned both above and belowsubstrate circuit board 56. Additional portion 99 formicrobattery 72 is shown underneath back-upbattery 74 since there are noelectronics 54 at this location in thedevice 97. Alternatively, a corresponding portion (not shown) can be added to back-upbattery 74 instead of additional portion 99 formicrobattery 72.Microbattery 72 can have astraight side 92 at afirst end 94 ofmicrobattery 72 and adjacent tosubstrate circuit board 56. Back-upbattery 74 can have astraight side 76 adjacent tosubstrate circuit board 56.Microbattery 72 can have acurved side 62 adjacent toouter housing 52 at asecond end 96 ofmicrobattery 72. Back-upbattery 74 can have acurved side 78 adjacentouter housing 52. In FIG. 3C,electronics 54 are positioned above and belowsubstrate circuit board 56. - Another embodiment of the present invention is shown in FIGS. 4A and 4B. In the embodiment shown, a
device 100 has anouter housing 102, asubstrate circuit board 106, andelectronics 104 on the substrate circuit board.Device 100 further has a rechargeable thin-film microbattery 108 underneathsubstrate circuit board 106. Preferably, thesubstrate circuit board 106 and themicrobattery 108 are oval in shape. Microbattery 108 can have acurved side 110, andsubstrate circuit board 106 can have acurved side 112, which are shown in FIGS. 4A and 4B.Device 100 can have aconnector block 109 that serves the same function and purpose asconnector block 59 in FIGS. 2A, 2B, 3A, 3B, 3C, 3D, and 3E. FIG. 4B is a cross-sectional view ofdevice 100 taken along line B-B in FIG. 4A. - Another embodiment of the present invention is shown in FIG. 5. The
device 120 shown in FIG. 5 is the same as thedevice 50 shown in FIGS. 2A and 2B, except that instead of asingle microbattery 58, the device now has two or more microbatteries that are stacked. As shown in FIG. 5,device 120 has threemicrobatteries - If desired, the
stacked microbatteries - The ability to dynamically create a higher voltage battery is an advantage when the voltage at the stimulation site is greater than the voltage of that of a single cell (i.e., 4 volts in the example above). In current medical devices, this multiplication of battery voltage is typically achieved by dynamically reconfigureable capacitors. The capacitors are charged in parallel to the voltage of the single cell battery, and then are reconfigured in series to create the desired stimulation voltage. The dynamically reconfigureable battery of the present invention eliminates the capacitor components required for reconfiguration, thereby creating a simpler, and more volumetrically efficient device.
- In a preferred embodiment, the rechargeable thin-film microbattery lies in a plane that is parallel to the substrate circuit board containing the electronics. In a preferred embodiment, the electronics are on a top side of the substrate circuit board, and the rechargeable thin-film microbattery is positioned underneath a bottom side of the substrate circuit board. In a further preferred embodiment, the rechargeable thin-film microbattery is deposited on the bottom side of the substrate circuit board.
- In an alternative embodiment, the rechargeable thin-film microbattery lies in a plan that is parallel to the substrate circuit board and the device includes a back-up battery adjacent to the circuit board and the rechargeable thin-film microbattery.
- In an alternative embodiment, some of the electronics are located on the top side of the substrate circuit board, and some of the electronics are located on the bottom side of the substrate circuit board, and the rechargeable thin-film microbattery is located underneath or over the back-up battery, and both batteries are located adjacent to the substrate circuit board.
- In an alternative embodiment, the rechargeable thin-film microbattery lies in a plane that is parallel to the substrate circuit board, and the microbattery is positioned underneath a bottom side of the substrate circuit board and is underneath at least a portion of a back-up battery that is adjacent to the substrate circuit board.
- The present invention provides many advantages over current implantable medical devices, including but not limited to: (1) an implantable medical device with a power source devoid of volatile components; (2) an implantable medical device with a power source that does not require an independent, hermetic compartment within the an implantable medical device to separate the power source from other components of the device; (3) increased design flexibility since the power source of the implantable medical device can be configured in a wide variety of shapes, including thin film shapes that can overlay other components of the implantable medical device, such as a microprocessor and/or electronic circuitry; (4) an implantable medical device with greater volumetric efficiency (that is, more electrical power without increasing the size of the implantable medical device); (5) simpler manufacturing steps to make an implantable medical device; (6) elimination of electrical feedthroughs between the power source and the electronics; and (7) elimination of need to check against leaks of battery liquids (that is, verification of seal integrity).
- The thin-film battery of the present invention can be made in accordance with methods taught in U.S. Pat. Nos. 5,338,625, 5,561,004, and 6,168,884 (all of which are incorporated herein by reference).
- In a preferred embodiment, the thin-film battery may incorporate a protective coating to protect the power source from ambient conditions (particularly moisture) prior to assembly of the power source into the implantable medical device. Such a coating is described in U.S. Pat. No. 5,561,004 (which is incorporated herein by reference). However, coatings such as this are not hermetic and are intended merely to provide a temporary protection of the battery materials from the atmosphere, not protection of the electronics from the battery materials. Alternate forms of the thin film battery that do not contain metallic lithium prior to the first charge of the battery may not require a protective coating (e.g., the battery disclosed in U.S. Pat. No. 6,168,884).
- The implantable medical devices of the present invention provide the following advantages over typical implantable medical devices with respect to volumetric efficiency: (1) no separator is required—the thin layer of solid-state electrolyte provides the separator function; (2) no conductive diluents or binders are required—the cathode is 100% active; (3) there is no need for “excess” liquid electrolyte to cover the cathode and the anode; (4) no electrical feed throughs are required between the thin-film battery and the electronics; and (5) there is no separate battery case since the battery can be deposited on a thin substrate.
- The implantable medical device of the present invention provides the following advantages over typical implantable medical devices with respect to packaging: (1) the design shape of the power source is not limited to circular shapes (such as a thin disk or cylinder), which is a shape that does not package efficiently in implantable medical devices and tend to result in a large amount of unusable volume within the device; (2) there is no need to achieve an adequate seal as the dimension of the seal area increases, and thus it is easier to build a thin-film battery with a large surface area; and (3) the thinness of the power source is not as limited by feedthrough dimensions, electrode handling properties or tolerances of the case and cover materials as the prior art devices.
- Thus, the thin-film batteries of the present invention provide the certain advantages with respect to thinness and efficient packaging. For example, in the present invention, active materials are deposited on a thin substrate that can be large in surface area. In some cases, a limited degree of substrate flexibility may also be possible. When larger capacities are required, it may be possible to deposit several layers of active materials or stack and interconnect several cells, each deposited on its own substrate. The deposit of several layers of active materials may be accomplished in accordance with the methods disclosed in U.S. Pat. No. 5,569,520, which is incorporated herein by reference.
- In addition, the substrate has essentially unlimited shape flexibility, thereby allowing the battery to fit efficiently into the shape of the implanted device. In accordance with the present invention, smaller medical devices can be designed so that they can be placed within a human being closer to a target site than are possible with current medical devices. By placing the medical device closer to the target site, less problems in transfer of electrical stimulation therapy are encountered.
- Further, smaller medical devices can be designed so that they can be placed within a human being at a location that will be less noticeable or not noticeable by a viewer looking at the human who has the implanted medical device.
- The thinness of battery and substrate in accordance with the present invention allows the battery to be stacked with other components. For example, the rechargeable thin-film battery of the present invention may be stacked with a back-up battery, stacked with the circuit, or located across the entire shield of the implanted device (i.e., stacked with all components).
- In addition, the active materials can be placed directly onto the same substrate as the circuit components. A substrate can be populated by circuit components on one side of the substrate, and by active battery materials on the other side of the substrate.
- The present invention also provides advantages over current implantable medical devices with respect to the charging coil. Currently, rechargeable batteries in implantable medical devices involve recharging by induction. This requires incorporation of a secondary coil in the implanted medical device. Typically, the coil is a discrete component that is wound from wire and located either internal to the device or encased in polymer and located on an external surface of the device.
- In accordance with the present invention, it may be possible to deposit a coil on the same substrate as the battery. This could be accomplished at the same time that the current collectors and contacts are being deposited for the battery.
- The present invention also provides manufacturing advantages over the manufacturing methods of conventional implantable medical devices. More specifically, the fabrication of the battery and device can be more easily automated and justified for smaller volumes. As previously noted, the batteries can be fabricated on the same substrate as the circuit. Further, the battery can be exposed to solder-reflow conditions without damage. See U.S. Pat. No. 6,168,884, which is incorporated herein by reference.
- In addition, conventional rechargeable batteries suffer from several characteristics that limit their usefulness in implantable medical devices, including: (1) cycle-dependant capacity fade (in other words, upon repeated charge/discharge cycles, the useable capacity of the battery gradually declines); (2) limited useful cycle life (most rechargeable batteries range from about 300 to 1500 cycles); (3) time-dependant capacity fade (even without charge/discharge cycling, the useable capacity of the battery declines over time due to a variety of loss mechanisms—most rechargeable batteries have a lifetime of only a few years when used under the most ideal circumstances; (4) history-dependant capacity fade (“memory effect”; many rechargeable batteries suffer a loss of usable capacity if they are not fully charged and discharged. The requirement to fully charge and discharge a battery is highly undesirable in an implanted device.)
- Thus, the implantable medical device of the present invention provides the following further advantages over conventional devices: (1) nearly unlimited cycle life—Charge/discharge cycles in excess of 50,000 have been demonstrated; (2) little or no time-dependent capacity loss; and (3) no “memory effect.”
- The present invention has been described in detail with particular reference to certain preferred embodiments thereof, and those of skill in the art will appreciate that variations and modifications are within the spirit and scope of the present invention as set forth in the following claims.
Claims (16)
1. An implantable medical device comprising an outer housing, the outer housing comprising at least one curved portion, electronics within the outer housing, the electronics located on a substrate circuit board, and a rechargeable thin-film microbattery within the outer housing, the rechargeable thin-film microbattery having a solid-state electrolyte, wherein the rechargeable thin-film microbattery is devoid of liquids or other volatile materials from which the electronics must be protected, wherein the rechargeable thin-film microbattery has a substantially straight first side that is adjacent to the substrate circuit board, and a substantially curved second side that is adjacent to the at least one curved portion of the outer housing to reduce wasted space between the rechargeable thin-film microbattery and the at least one curved portion of the outer housing.
2. The implantable medical device of claim 1 , wherein the rechargeable thin-film microbattery lies in a plane that is parallel to the substrate circuit board containing the electronics.
3. The implantable medical device of claim 1 , wherein the device includes a back-up battery adjacent to the circuit board and the rechargeable thin-film microbattery.
4. The implantable medical device of claim 3 , wherein a first group of the electronics is located on a first face of the substrate circuit board, and a second group of the electronics is located on the second face of the substrate circuit board, and the rechargeable thin-film microbattery is located underneath or over the back-up battery, and both batteries are located adjacent to the substrate circuit board.
5. The implantable medical device of claim 1 , wherein the electronics are located on at least a first face of the substrate circuit board and the rechargeable thin-film microbattery is positioned adjacent a second face of the substrate circuit board and is adjacent to at least a portion of a back-up battery that is adjacent to the substrate circuit board.
6. The implantable medical device of claim 1 , wherein there are two or more microbatteries that are stacked in series or in parallel.
7. The implantable medical device of claim 6 , wherein the microbatteries are dynamically reconfigureable via programming of the device to provide a series connection, a parallel connection, or a combination of series and parallel connections.
8. The implantable medical device of claim 1 , wherein the electronics are on a first face of the substrate circuit board, and the rechargeable thin-film microbattery is positioned underneath a second face of the substrate circuit board, the second face being on the side of the substrate circuit board opposite the first face.
9. The implantable medical device of claim 8 , further comprising a back-up battery adjacent to the circuit board and the rechargeable thin-film microbattery.
10. The implantable medical device of claim 1 , wherein the electronics are located on at least a first face of the substrate circuit board and the rechargeable thin-film microbattery is positioned underneath a second face of the substrate circuit board and is adjacent to at least a portion of a back-up battery that is adjacent to the substrate circuit board.
11. The implantable medical device of claim 1 , wherein the electronics are located on at least a first face of the substrate circuit board and the rechargeable thin-film microbattery is positioned underneath a second face of the substrate circuit board and underneath a back-up battery that is adjacent to the substrate circuit board.
12. The implantable medical device of claim 1 , wherein electronics are located on at least a first face of the substrate circuit board and the rechargeable thin-film microbattery is positioned adjacent a second face of the substrate circuit board and at least a portion of a back-up battery that is adjacent to the substrate circuit board.
13. The implantable medical device of claim 4 , wherein the rechargeable thin-film microbattery is positioned underneath the second group of electronics and is located underneath or over the back-up battery.
14. The implantable medical device of claim 3 , wherein a first group of the electronics is located on a first face of the substrate circuit board, and a second group of the electronics is located on the second face of the substrate circuit board.
15. The implantable medical device of claim 9 , wherein a first group of the electronics is located on a first face of the substrate circuit board, and a second group of the electronics is located on the second face of the substrate circuit board.
16. The implantable medical device of claim 1 , wherein a first group of the electronics is located on a first face of the substrate circuit board, and a second group of the electronics is located on the second face of the substrate circuit board.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/855,832 US20040220643A1 (en) | 2001-04-27 | 2004-05-27 | Implantable medical device with rechargeable thin-film microbattery power source |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/843,673 US6782290B2 (en) | 2001-04-27 | 2001-04-27 | Implantable medical device with rechargeable thin-film microbattery power source |
US10/855,832 US20040220643A1 (en) | 2001-04-27 | 2004-05-27 | Implantable medical device with rechargeable thin-film microbattery power source |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/843,673 Division US6782290B2 (en) | 2001-04-27 | 2001-04-27 | Implantable medical device with rechargeable thin-film microbattery power source |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040220643A1 true US20040220643A1 (en) | 2004-11-04 |
Family
ID=25290683
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/843,673 Expired - Fee Related US6782290B2 (en) | 2001-04-27 | 2001-04-27 | Implantable medical device with rechargeable thin-film microbattery power source |
US10/855,832 Abandoned US20040220643A1 (en) | 2001-04-27 | 2004-05-27 | Implantable medical device with rechargeable thin-film microbattery power source |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/843,673 Expired - Fee Related US6782290B2 (en) | 2001-04-27 | 2001-04-27 | Implantable medical device with rechargeable thin-film microbattery power source |
Country Status (2)
Country | Link |
---|---|
US (2) | US6782290B2 (en) |
WO (1) | WO2002087697A2 (en) |
Cited By (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060263686A1 (en) * | 2005-05-19 | 2006-11-23 | Medtronic, Inc. | Lithium battery manufacturing method |
WO2008052136A3 (en) * | 2006-10-25 | 2008-10-23 | Proteus Biomedical Inc | Controlled activation ingestible identifier |
US20090181298A1 (en) * | 2008-01-10 | 2009-07-16 | Eaglepicher Energy Products Corporation | Integral electrochemical device |
US20090202899A1 (en) * | 2008-02-11 | 2009-08-13 | Pyszczek Michael F | Electrical apparatus with integral thin film solid state battery and methods of manufacture |
US7978064B2 (en) | 2005-04-28 | 2011-07-12 | Proteus Biomedical, Inc. | Communication system with partial power source |
US8036748B2 (en) | 2008-11-13 | 2011-10-11 | Proteus Biomedical, Inc. | Ingestible therapy activator system and method |
US8054140B2 (en) | 2006-10-17 | 2011-11-08 | Proteus Biomedical, Inc. | Low voltage oscillator for medical devices |
US8055334B2 (en) | 2008-12-11 | 2011-11-08 | Proteus Biomedical, Inc. | Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same |
US8115618B2 (en) | 2007-05-24 | 2012-02-14 | Proteus Biomedical, Inc. | RFID antenna for in-body device |
US8114021B2 (en) | 2008-12-15 | 2012-02-14 | Proteus Biomedical, Inc. | Body-associated receiver and method |
WO2012033752A1 (en) * | 2010-09-07 | 2012-03-15 | Elenza, Inc. | Installation and sealing of a battery on a thin glass wafer to supply power to an intraocular implant |
US8258962B2 (en) | 2008-03-05 | 2012-09-04 | Proteus Biomedical, Inc. | Multi-mode communication ingestible event markers and systems, and methods of using the same |
US8540664B2 (en) | 2009-03-25 | 2013-09-24 | Proteus Digital Health, Inc. | Probablistic pharmacokinetic and pharmacodynamic modeling |
US8540633B2 (en) | 2008-08-13 | 2013-09-24 | Proteus Digital Health, Inc. | Identifier circuits for generating unique identifiable indicators and techniques for producing same |
US8545402B2 (en) | 2009-04-28 | 2013-10-01 | Proteus Digital Health, Inc. | Highly reliable ingestible event markers and methods for using the same |
US8547248B2 (en) | 2005-09-01 | 2013-10-01 | Proteus Digital Health, Inc. | Implantable zero-wire communications system |
US8558563B2 (en) | 2009-08-21 | 2013-10-15 | Proteus Digital Health, Inc. | Apparatus and method for measuring biochemical parameters |
US8597186B2 (en) | 2009-01-06 | 2013-12-03 | Proteus Digital Health, Inc. | Pharmaceutical dosages delivery system |
US8718193B2 (en) | 2006-11-20 | 2014-05-06 | Proteus Digital Health, Inc. | Active signal processing personal health signal receivers |
US8730031B2 (en) | 2005-04-28 | 2014-05-20 | Proteus Digital Health, Inc. | Communication system using an implantable device |
US8784308B2 (en) | 2009-12-02 | 2014-07-22 | Proteus Digital Health, Inc. | Integrated ingestible event marker system with pharmaceutical product |
US8802183B2 (en) | 2005-04-28 | 2014-08-12 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
US8836513B2 (en) | 2006-04-28 | 2014-09-16 | Proteus Digital Health, Inc. | Communication system incorporated in an ingestible product |
US8858432B2 (en) | 2007-02-01 | 2014-10-14 | Proteus Digital Health, Inc. | Ingestible event marker systems |
US8868453B2 (en) | 2009-11-04 | 2014-10-21 | Proteus Digital Health, Inc. | System for supply chain management |
US8912908B2 (en) | 2005-04-28 | 2014-12-16 | Proteus Digital Health, Inc. | Communication system with remote activation |
US8932221B2 (en) | 2007-03-09 | 2015-01-13 | Proteus Digital Health, Inc. | In-body device having a multi-directional transmitter |
US8956287B2 (en) | 2006-05-02 | 2015-02-17 | Proteus Digital Health, Inc. | Patient customized therapeutic regimens |
US8956288B2 (en) | 2007-02-14 | 2015-02-17 | Proteus Digital Health, Inc. | In-body power source having high surface area electrode |
US8961412B2 (en) | 2007-09-25 | 2015-02-24 | Proteus Digital Health, Inc. | In-body device with virtual dipole signal amplification |
US9014779B2 (en) | 2010-02-01 | 2015-04-21 | Proteus Digital Health, Inc. | Data gathering system |
US9107806B2 (en) | 2010-11-22 | 2015-08-18 | Proteus Digital Health, Inc. | Ingestible device with pharmaceutical product |
US9149423B2 (en) | 2009-05-12 | 2015-10-06 | Proteus Digital Health, Inc. | Ingestible event markers comprising an ingestible component |
US9198608B2 (en) | 2005-04-28 | 2015-12-01 | Proteus Digital Health, Inc. | Communication system incorporated in a container |
US9235683B2 (en) | 2011-11-09 | 2016-01-12 | Proteus Digital Health, Inc. | Apparatus, system, and method for managing adherence to a regimen |
US9268909B2 (en) | 2012-10-18 | 2016-02-23 | Proteus Digital Health, Inc. | Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device |
US9270025B2 (en) | 2007-03-09 | 2016-02-23 | Proteus Digital Health, Inc. | In-body device having deployable antenna |
US9270503B2 (en) | 2013-09-20 | 2016-02-23 | Proteus Digital Health, Inc. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
US9271897B2 (en) | 2012-07-23 | 2016-03-01 | Proteus Digital Health, Inc. | Techniques for manufacturing ingestible event markers comprising an ingestible component |
US9439566B2 (en) | 2008-12-15 | 2016-09-13 | Proteus Digital Health, Inc. | Re-wearable wireless device |
US9439599B2 (en) | 2011-03-11 | 2016-09-13 | Proteus Digital Health, Inc. | Wearable personal body associated device with various physical configurations |
US9577864B2 (en) | 2013-09-24 | 2017-02-21 | Proteus Digital Health, Inc. | Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance |
US9597487B2 (en) | 2010-04-07 | 2017-03-21 | Proteus Digital Health, Inc. | Miniature ingestible device |
US9603550B2 (en) | 2008-07-08 | 2017-03-28 | Proteus Digital Health, Inc. | State characterization based on multi-variate data fusion techniques |
US9659423B2 (en) | 2008-12-15 | 2017-05-23 | Proteus Digital Health, Inc. | Personal authentication apparatus system and method |
US9756874B2 (en) | 2011-07-11 | 2017-09-12 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
US9796576B2 (en) | 2013-08-30 | 2017-10-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
US9883819B2 (en) | 2009-01-06 | 2018-02-06 | Proteus Digital Health, Inc. | Ingestion-related biofeedback and personalized medical therapy method and system |
US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
US10175376B2 (en) | 2013-03-15 | 2019-01-08 | Proteus Digital Health, Inc. | Metal detector apparatus, system, and method |
US10187121B2 (en) | 2016-07-22 | 2019-01-22 | Proteus Digital Health, Inc. | Electromagnetic sensing and detection of ingestible event markers |
US10223905B2 (en) | 2011-07-21 | 2019-03-05 | Proteus Digital Health, Inc. | Mobile device and system for detection and communication of information received from an ingestible device |
US10398161B2 (en) | 2014-01-21 | 2019-09-03 | Proteus Digital Heal Th, Inc. | Masticable ingestible product and communication system therefor |
US10529044B2 (en) | 2010-05-19 | 2020-01-07 | Proteus Digital Health, Inc. | Tracking and delivery confirmation of pharmaceutical products |
US11051543B2 (en) | 2015-07-21 | 2021-07-06 | Otsuka Pharmaceutical Co. Ltd. | Alginate on adhesive bilayer laminate film |
US11149123B2 (en) | 2013-01-29 | 2021-10-19 | Otsuka Pharmaceutical Co., Ltd. | Highly-swellable polymeric films and compositions comprising the same |
US11158149B2 (en) | 2013-03-15 | 2021-10-26 | Otsuka Pharmaceutical Co., Ltd. | Personal authentication apparatus system and method |
US11529071B2 (en) | 2016-10-26 | 2022-12-20 | Otsuka Pharmaceutical Co., Ltd. | Methods for manufacturing capsules with ingestible event markers |
US11612321B2 (en) | 2007-11-27 | 2023-03-28 | Otsuka Pharmaceutical Co., Ltd. | Transbody communication systems employing communication channels |
US11744481B2 (en) | 2013-03-15 | 2023-09-05 | Otsuka Pharmaceutical Co., Ltd. | System, apparatus and methods for data collection and assessing outcomes |
US11950615B2 (en) | 2021-11-10 | 2024-04-09 | Otsuka Pharmaceutical Co., Ltd. | Masticable ingestible product and communication system therefor |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070264564A1 (en) | 2006-03-16 | 2007-11-15 | Infinite Power Solutions, Inc. | Thin film battery on an integrated circuit or circuit board and method thereof |
US8236443B2 (en) | 2002-08-09 | 2012-08-07 | Infinite Power Solutions, Inc. | Metal film encapsulation |
US8431264B2 (en) | 2002-08-09 | 2013-04-30 | Infinite Power Solutions, Inc. | Hybrid thin-film battery |
US8404376B2 (en) | 2002-08-09 | 2013-03-26 | Infinite Power Solutions, Inc. | Metal film encapsulation |
US8021778B2 (en) | 2002-08-09 | 2011-09-20 | Infinite Power Solutions, Inc. | Electrochemical apparatus with barrier layer protected substrate |
US8394522B2 (en) | 2002-08-09 | 2013-03-12 | Infinite Power Solutions, Inc. | Robust metal film encapsulation |
US8445130B2 (en) | 2002-08-09 | 2013-05-21 | Infinite Power Solutions, Inc. | Hybrid thin-film battery |
US9793523B2 (en) | 2002-08-09 | 2017-10-17 | Sapurast Research Llc | Electrochemical apparatus with barrier layer protected substrate |
US8728285B2 (en) | 2003-05-23 | 2014-05-20 | Demaray, Llc | Transparent conductive oxides |
US7217279B2 (en) * | 2003-11-14 | 2007-05-15 | Ethicon, Inc. | Suture loop anchor |
US20060111752A1 (en) * | 2004-11-22 | 2006-05-25 | Wilson Greatbatch | High-energy battery power source for implantable medical use |
US20060122655A1 (en) * | 2004-12-02 | 2006-06-08 | Wilson Greatbatch | High-energy battery power source with low internal self-discharge for implantable medical use |
US20060122657A1 (en) * | 2004-12-04 | 2006-06-08 | Jeffrey Deal | Programmable voltage-waveform-generating battery power source for implantable medical use |
US7959769B2 (en) | 2004-12-08 | 2011-06-14 | Infinite Power Solutions, Inc. | Deposition of LiCoO2 |
TWI331634B (en) | 2004-12-08 | 2010-10-11 | Infinite Power Solutions Inc | Deposition of licoo2 |
US20060247715A1 (en) * | 2005-04-29 | 2006-11-02 | Youker Nick A | Method and apparatus for an implantable pulse generator with a stacked battery and capacitor |
US20070142696A1 (en) | 2005-12-08 | 2007-06-21 | Ventrassist Pty Ltd | Implantable medical devices |
US20070254212A1 (en) * | 2006-04-28 | 2007-11-01 | Viavattine Joseph J | Battery assembly for use in implantable medical device |
US8874214B2 (en) * | 2006-08-28 | 2014-10-28 | Cardiac Pacemakers, Inc. | Implantable pulse generator with a stacked capacitor, battery, and electronics |
EP2067163A4 (en) | 2006-09-29 | 2009-12-02 | Infinite Power Solutions Inc | Masking of and material constraint for depositing battery layers on flexible substrates |
US8197781B2 (en) | 2006-11-07 | 2012-06-12 | Infinite Power Solutions, Inc. | Sputtering target of Li3PO4 and method for producing same |
KR20150128817A (en) | 2007-12-21 | 2015-11-18 | 사푸라스트 리써치 엘엘씨 | Method for sputter targets for electrolyte films |
US8268488B2 (en) | 2007-12-21 | 2012-09-18 | Infinite Power Solutions, Inc. | Thin film electrolyte for thin film batteries |
JP5705549B2 (en) | 2008-01-11 | 2015-04-22 | インフィニット パワー ソリューションズ, インコーポレイテッド | Thin film encapsulation for thin film batteries and other devices |
CN101983469B (en) | 2008-04-02 | 2014-06-04 | 无穷动力解决方案股份有限公司 | Passive over/under voltage control and protection for energy storage devices associated with energy harvesting |
JP5185008B2 (en) * | 2008-07-31 | 2013-04-17 | オリンパスメディカルシステムズ株式会社 | Capsule medical device |
WO2010019577A1 (en) | 2008-08-11 | 2010-02-18 | Infinite Power Solutions, Inc. | Energy device with integral collector surface for electromagnetic energy harvesting and method thereof |
JP5650646B2 (en) | 2008-09-12 | 2015-01-07 | インフィニット パワー ソリューションズ, インコーポレイテッド | Energy device with integral conductive surface for data communication via electromagnetic energy and method for data communication via electromagnetic energy |
US8508193B2 (en) | 2008-10-08 | 2013-08-13 | Infinite Power Solutions, Inc. | Environmentally-powered wireless sensor module |
WO2010051500A1 (en) * | 2008-10-31 | 2010-05-06 | Medtronic, Inc. | Therapy system including cardiac rhythm therapy and neurostimulation capabilities |
KR101792287B1 (en) | 2009-09-01 | 2017-10-31 | 사푸라스트 리써치 엘엘씨 | Printed circuit board with integrated thin film battery |
KR101930561B1 (en) | 2010-06-07 | 2018-12-18 | 사푸라스트 리써치 엘엘씨 | Rechargeable high-density electrochemical device |
US9059435B2 (en) * | 2012-01-27 | 2015-06-16 | Medtronic, Inc. | Medical device battery enclosure |
US9252415B2 (en) | 2012-06-15 | 2016-02-02 | Medtronic, Inc. | Power sources suitable for use in implantable medical devices and corresponding fabrication methods |
US8824161B2 (en) | 2012-06-15 | 2014-09-02 | Medtronic, Inc. | Integrated circuit packaging for implantable medical devices |
WO2014018946A1 (en) | 2012-07-26 | 2014-01-30 | Smith & Nephew, Inc. | Knotless anchor for instability repair |
JP6382237B2 (en) | 2013-03-06 | 2018-08-29 | スミス アンド ネフュー インコーポレーテッドSmith & Nephew,Inc. | Micro anchor |
US10096802B2 (en) | 2014-04-08 | 2018-10-09 | International Business Machines Corporation | Homogeneous solid metallic anode for thin film microbattery |
US9508566B2 (en) | 2014-08-15 | 2016-11-29 | International Business Machines Corporation | Wafer level overmold for three dimensional surfaces |
US10105082B2 (en) | 2014-08-15 | 2018-10-23 | International Business Machines Corporation | Metal-oxide-semiconductor capacitor based sensor |
US10478259B2 (en) | 2016-06-09 | 2019-11-19 | Boston Scientific Scimed, Inc. | Medical device packaging with power source |
US10653183B2 (en) * | 2016-11-18 | 2020-05-19 | Rai Strategic Holdings, Inc. | Power source for an aerosol delivery device |
US10770698B1 (en) | 2017-06-09 | 2020-09-08 | Greatbatch Ltd. | Miniature electrochemical cell having a casing comprising opposed ceramic substrates secured together using a precious metal braze |
US11011787B2 (en) | 2018-01-08 | 2021-05-18 | Greatbatch Ltd. | Hermetic thin film electrochemical cells housed in a ceramic casing and activated with a solid electrolyte |
US10957884B1 (en) | 2018-01-08 | 2021-03-23 | Greatbatch Ltd. | Miniature electrochemical cells housed in a metallic casing having a glass-to-metal seal isolating the opposite polarity terminals |
EP3920792A4 (en) * | 2019-02-05 | 2022-11-02 | Commonwealth Scientific and Industrial Research Organisation | Brain activity monitoring |
US11075421B1 (en) | 2019-05-24 | 2021-07-27 | Greatbatch Ltd. | Miniature electrochemical cell having a casing of a metal container closed with a ceramic plate having a via hole supporting a platinum-containing conductive pathway |
US11114714B2 (en) | 2019-06-04 | 2021-09-07 | Greatbatch Ltd. | Miniature electrochemical cell having a casing of a metal container closed with a ceramic plate having two via holes supporting opposite polarity platinum-containing conductive pathways |
US20220379123A1 (en) * | 2020-01-31 | 2022-12-01 | Biotronik Se & Co. Kg | Implantable medical device comprising an energy storage device |
Citations (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3683926A (en) * | 1970-07-09 | 1972-08-15 | Dainippon Pharmaceutical Co | Tube for connecting blood vessels |
US4214586A (en) * | 1978-11-30 | 1980-07-29 | Ethicon, Inc. | Anastomotic coupling device |
US4230109A (en) * | 1978-08-21 | 1980-10-28 | Alan Geiss | Apparatus for securing couplings of intravenous and intra-arterial access systems |
US4265428A (en) * | 1978-09-13 | 1981-05-05 | Gambro Dialysatoren Gmbh & Co. Kg | Connection device for providing selective fluid communication between first and second conduits |
US4537183A (en) * | 1983-04-08 | 1985-08-27 | Mentor Corporation | Connector device for connecting elastic tubing of an implantable device |
US4547194A (en) * | 1984-03-16 | 1985-10-15 | Moorehead Harvey R | Hub assemblies and extensions for indwelling catheter tubes and method |
US4641860A (en) * | 1984-06-25 | 1987-02-10 | Berkley And Company, Inc. | Coupling for flexible tubing |
US4672979A (en) * | 1986-01-30 | 1987-06-16 | Cordis Corporation | Suture sleeve assembly |
US4682895A (en) * | 1985-08-06 | 1987-07-28 | Texas A&M University | Fiber optic probe for quantification of colorimetric reactions |
US4842592A (en) * | 1987-05-06 | 1989-06-27 | Teleflex Incorporated | Connector assembly |
US4917103A (en) * | 1985-09-18 | 1990-04-17 | C. R. Bard, Inc. | Guide wire extension |
US5036862A (en) * | 1987-04-06 | 1991-08-06 | Cordis Corporation | Implantable, self-retaining lead |
US5053015A (en) * | 1989-08-30 | 1991-10-01 | The Kendall Company | Locking catheter adapter |
US5107856A (en) * | 1991-01-10 | 1992-04-28 | Siemens-Pacesetter, Inc. | Multiple lead suture sleeve |
US5129891A (en) * | 1989-05-19 | 1992-07-14 | Strato Medical Corporation | Catheter attachment device |
US5152298A (en) * | 1991-04-16 | 1992-10-06 | Siemens Pacesetter, Inc. | Threaded suture sleeve |
US5178612A (en) * | 1990-10-10 | 1993-01-12 | Strato Medical Corporation | Compressible split cylinder bayonet locking device for attachment of a catheter to a fluid transfer device |
US5190529A (en) * | 1991-05-20 | 1993-03-02 | The Kendall Company | Advancement sleeve and adapter for a catheter |
US5226898A (en) * | 1989-08-30 | 1993-07-13 | The Kendall Company | Catheter adapter with strain relief |
US5242431A (en) * | 1992-06-11 | 1993-09-07 | Siemens Pacesetter, Inc. | Suture sleeve assembly with slidable compression collar |
US5360418A (en) * | 1992-07-15 | 1994-11-01 | Sherwood Medical Company | Connector for a thoracic catheter |
US5365944A (en) * | 1992-10-09 | 1994-11-22 | C. R. Bard, Inc. | Guidewire extension with self-latching detachable connector |
US5376108A (en) * | 1993-05-20 | 1994-12-27 | Telectronics Pacing Systems, Inc. | Electrode lead anchoring apparatus and method employing dual suture collars |
US5405339A (en) * | 1993-09-03 | 1995-04-11 | Medtronic, Inc. | Medical connector and method for connecting medical tubing |
US5423763A (en) * | 1993-06-17 | 1995-06-13 | Pacesetter, Inc. | Protective, visible suture sleeve for anchoring transvenous lead bodies |
US5562618A (en) * | 1994-01-21 | 1996-10-08 | Sims Deltec, Inc. | Portal assembly and catheter connector |
US5584874A (en) * | 1995-04-28 | 1996-12-17 | Medtronic, Inc. | Medical electrical lead having improved anchoring sleeve |
US5637102A (en) * | 1995-05-24 | 1997-06-10 | C. R. Bard, Inc. | Dual-type catheter connection system |
US5723053A (en) * | 1993-11-05 | 1998-03-03 | Seiko Epson Corporation | Ink jet print head and a method of manufacturing the same |
US5746722A (en) * | 1997-02-05 | 1998-05-05 | Medtronic, Inc. | Suture sleeve with circumferential lead locking device |
US5824032A (en) * | 1996-08-09 | 1998-10-20 | Medtronic Inc. | Medical electrical lead featuring a one piece lead anchoring sleeve with wrap-around locking arms |
US5961485A (en) * | 1993-03-16 | 1999-10-05 | Vas-Cath Incorporated | Coaxial dual lumen catheter |
US5984711A (en) * | 1998-09-10 | 1999-11-16 | Scimed Life Systems, Inc. | Methods and apparatus for increasing wire diameter to improve connectability |
US6013051A (en) * | 1998-10-22 | 2000-01-11 | Medtronic, Inc. | Filtered access port with filter bypass for accessing body fluid samples |
US6099519A (en) * | 1994-07-29 | 2000-08-08 | Tyco Healthcare Group Lp | Catheter sleeve connecting assembly |
US6190372B1 (en) * | 1998-08-14 | 2001-02-20 | Epimed International, Inc. | Catheter connector |
US6238369B1 (en) * | 1997-01-21 | 2001-05-29 | Vasco, Inc. | Method and systems for establishing vascular access |
US6264709B1 (en) * | 1998-08-21 | 2001-07-24 | Korea Institute Of Science And Tech. | Method for making electrical and electronic devices with vertically integrated and interconnected thin-film type battery |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52151835A (en) | 1976-04-30 | 1977-12-16 | Univ Johns Hopkins | Enclosed battery |
DE3507092A1 (en) | 1985-02-28 | 1986-08-28 | Siemens AG, 1000 Berlin und 8000 München | Tissue stimulator comprising a capsule which contains at least one battery and electronic components |
US5144946A (en) | 1991-08-05 | 1992-09-08 | Siemens Pacesetter, Inc. | Combined pacemaker substrate and electrical interconnect and method of assembly |
US5369351A (en) | 1992-02-18 | 1994-11-29 | Angeion Corporation | High voltage charge storage array for an impantable defibrillator |
US5338625A (en) | 1992-07-29 | 1994-08-16 | Martin Marietta Energy Systems, Inc. | Thin film battery and method for making same |
US5411537A (en) | 1993-10-29 | 1995-05-02 | Intermedics, Inc. | Rechargeable biomedical battery powered devices with recharging and control system therefor |
US5569520A (en) | 1994-01-12 | 1996-10-29 | Martin Marietta Energy Systems, Inc. | Rechargeable lithium battery for use in applications requiring a low to high power output |
US5561004A (en) | 1994-02-25 | 1996-10-01 | Bates; John B. | Packaging material for thin film lithium batteries |
US6273904B1 (en) | 1999-03-02 | 2001-08-14 | Light Sciences Corporation | Polymer battery for internal light device |
US6168884B1 (en) | 1999-04-02 | 2001-01-02 | Lockheed Martin Energy Research Corporation | Battery with an in-situ activation plated lithium anode |
DE10041728A1 (en) | 2000-08-25 | 2002-03-21 | Implex Hear Tech Ag | Implantable medicinal device with hermetically sealed housing has storage device accommodated directly within hermetically sealed housing without housing of its own |
-
2001
- 2001-04-27 US US09/843,673 patent/US6782290B2/en not_active Expired - Fee Related
- 2001-12-26 WO PCT/US2001/050486 patent/WO2002087697A2/en not_active Application Discontinuation
-
2004
- 2004-05-27 US US10/855,832 patent/US20040220643A1/en not_active Abandoned
Patent Citations (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3683926A (en) * | 1970-07-09 | 1972-08-15 | Dainippon Pharmaceutical Co | Tube for connecting blood vessels |
US4230109A (en) * | 1978-08-21 | 1980-10-28 | Alan Geiss | Apparatus for securing couplings of intravenous and intra-arterial access systems |
US4265428A (en) * | 1978-09-13 | 1981-05-05 | Gambro Dialysatoren Gmbh & Co. Kg | Connection device for providing selective fluid communication between first and second conduits |
US4214586A (en) * | 1978-11-30 | 1980-07-29 | Ethicon, Inc. | Anastomotic coupling device |
US4537183A (en) * | 1983-04-08 | 1985-08-27 | Mentor Corporation | Connector device for connecting elastic tubing of an implantable device |
US4547194A (en) * | 1984-03-16 | 1985-10-15 | Moorehead Harvey R | Hub assemblies and extensions for indwelling catheter tubes and method |
US4641860A (en) * | 1984-06-25 | 1987-02-10 | Berkley And Company, Inc. | Coupling for flexible tubing |
US4682895A (en) * | 1985-08-06 | 1987-07-28 | Texas A&M University | Fiber optic probe for quantification of colorimetric reactions |
US4917103A (en) * | 1985-09-18 | 1990-04-17 | C. R. Bard, Inc. | Guide wire extension |
US4672979A (en) * | 1986-01-30 | 1987-06-16 | Cordis Corporation | Suture sleeve assembly |
US5036862A (en) * | 1987-04-06 | 1991-08-06 | Cordis Corporation | Implantable, self-retaining lead |
US4842592A (en) * | 1987-05-06 | 1989-06-27 | Teleflex Incorporated | Connector assembly |
US5129891A (en) * | 1989-05-19 | 1992-07-14 | Strato Medical Corporation | Catheter attachment device |
US5226898A (en) * | 1989-08-30 | 1993-07-13 | The Kendall Company | Catheter adapter with strain relief |
US5053015A (en) * | 1989-08-30 | 1991-10-01 | The Kendall Company | Locking catheter adapter |
US5178612A (en) * | 1990-10-10 | 1993-01-12 | Strato Medical Corporation | Compressible split cylinder bayonet locking device for attachment of a catheter to a fluid transfer device |
US5312337A (en) * | 1990-10-10 | 1994-05-17 | Strato Medical Corporation | Catheter attachment device |
US5107856A (en) * | 1991-01-10 | 1992-04-28 | Siemens-Pacesetter, Inc. | Multiple lead suture sleeve |
US5152298A (en) * | 1991-04-16 | 1992-10-06 | Siemens Pacesetter, Inc. | Threaded suture sleeve |
US5190529A (en) * | 1991-05-20 | 1993-03-02 | The Kendall Company | Advancement sleeve and adapter for a catheter |
US5242431A (en) * | 1992-06-11 | 1993-09-07 | Siemens Pacesetter, Inc. | Suture sleeve assembly with slidable compression collar |
US5360418A (en) * | 1992-07-15 | 1994-11-01 | Sherwood Medical Company | Connector for a thoracic catheter |
US5365944A (en) * | 1992-10-09 | 1994-11-22 | C. R. Bard, Inc. | Guidewire extension with self-latching detachable connector |
US5961485A (en) * | 1993-03-16 | 1999-10-05 | Vas-Cath Incorporated | Coaxial dual lumen catheter |
US5376108A (en) * | 1993-05-20 | 1994-12-27 | Telectronics Pacing Systems, Inc. | Electrode lead anchoring apparatus and method employing dual suture collars |
US5628780A (en) * | 1993-06-17 | 1997-05-13 | Pacesetter, Inc. | Protective, visible suture sleeve for anchoring transvenous lead bodies |
US5423763A (en) * | 1993-06-17 | 1995-06-13 | Pacesetter, Inc. | Protective, visible suture sleeve for anchoring transvenous lead bodies |
US5405339A (en) * | 1993-09-03 | 1995-04-11 | Medtronic, Inc. | Medical connector and method for connecting medical tubing |
US5723053A (en) * | 1993-11-05 | 1998-03-03 | Seiko Epson Corporation | Ink jet print head and a method of manufacturing the same |
US5743873A (en) * | 1994-01-21 | 1998-04-28 | Sims Deltec, Inc. | Methods for using catheter connectors and portals, and methods of assembly |
US5562618A (en) * | 1994-01-21 | 1996-10-08 | Sims Deltec, Inc. | Portal assembly and catheter connector |
US5632729A (en) * | 1994-01-21 | 1997-05-27 | Sims Deltec, Inc. | Catheter connector |
US5613945A (en) * | 1994-01-21 | 1997-03-25 | Sims Deltec, Inc. | Portal assembly |
US6099519A (en) * | 1994-07-29 | 2000-08-08 | Tyco Healthcare Group Lp | Catheter sleeve connecting assembly |
US5584874A (en) * | 1995-04-28 | 1996-12-17 | Medtronic, Inc. | Medical electrical lead having improved anchoring sleeve |
US5637102A (en) * | 1995-05-24 | 1997-06-10 | C. R. Bard, Inc. | Dual-type catheter connection system |
US5824032A (en) * | 1996-08-09 | 1998-10-20 | Medtronic Inc. | Medical electrical lead featuring a one piece lead anchoring sleeve with wrap-around locking arms |
US6238369B1 (en) * | 1997-01-21 | 2001-05-29 | Vasco, Inc. | Method and systems for establishing vascular access |
US5746722A (en) * | 1997-02-05 | 1998-05-05 | Medtronic, Inc. | Suture sleeve with circumferential lead locking device |
US6254589B1 (en) * | 1998-01-15 | 2001-07-03 | Epimed International, Inc. | Catheter connector |
US6190372B1 (en) * | 1998-08-14 | 2001-02-20 | Epimed International, Inc. | Catheter connector |
US6264709B1 (en) * | 1998-08-21 | 2001-07-24 | Korea Institute Of Science And Tech. | Method for making electrical and electronic devices with vertically integrated and interconnected thin-film type battery |
US5984711A (en) * | 1998-09-10 | 1999-11-16 | Scimed Life Systems, Inc. | Methods and apparatus for increasing wire diameter to improve connectability |
US6013051A (en) * | 1998-10-22 | 2000-01-11 | Medtronic, Inc. | Filtered access port with filter bypass for accessing body fluid samples |
Cited By (116)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9962107B2 (en) | 2005-04-28 | 2018-05-08 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
US7978064B2 (en) | 2005-04-28 | 2011-07-12 | Proteus Biomedical, Inc. | Communication system with partial power source |
US8816847B2 (en) | 2005-04-28 | 2014-08-26 | Proteus Digital Health, Inc. | Communication system with partial power source |
US9198608B2 (en) | 2005-04-28 | 2015-12-01 | Proteus Digital Health, Inc. | Communication system incorporated in a container |
US9649066B2 (en) | 2005-04-28 | 2017-05-16 | Proteus Digital Health, Inc. | Communication system with partial power source |
US8802183B2 (en) | 2005-04-28 | 2014-08-12 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
US8730031B2 (en) | 2005-04-28 | 2014-05-20 | Proteus Digital Health, Inc. | Communication system using an implantable device |
US9161707B2 (en) | 2005-04-28 | 2015-10-20 | Proteus Digital Health, Inc. | Communication system incorporated in an ingestible product |
US8912908B2 (en) | 2005-04-28 | 2014-12-16 | Proteus Digital Health, Inc. | Communication system with remote activation |
US11476952B2 (en) | 2005-04-28 | 2022-10-18 | Otsuka Pharmaceutical Co., Ltd. | Pharma-informatics system |
US9439582B2 (en) | 2005-04-28 | 2016-09-13 | Proteus Digital Health, Inc. | Communication system with remote activation |
US9681842B2 (en) | 2005-04-28 | 2017-06-20 | Proteus Digital Health, Inc. | Pharma-informatics system |
US8847766B2 (en) | 2005-04-28 | 2014-09-30 | Proteus Digital Health, Inc. | Pharma-informatics system |
US9597010B2 (en) | 2005-04-28 | 2017-03-21 | Proteus Digital Health, Inc. | Communication system using an implantable device |
US8674825B2 (en) | 2005-04-28 | 2014-03-18 | Proteus Digital Health, Inc. | Pharma-informatics system |
US10517507B2 (en) | 2005-04-28 | 2019-12-31 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
US9119554B2 (en) | 2005-04-28 | 2015-09-01 | Proteus Digital Health, Inc. | Pharma-informatics system |
US10610128B2 (en) | 2005-04-28 | 2020-04-07 | Proteus Digital Health, Inc. | Pharma-informatics system |
US10542909B2 (en) | 2005-04-28 | 2020-01-28 | Proteus Digital Health, Inc. | Communication system with partial power source |
US20060263686A1 (en) * | 2005-05-19 | 2006-11-23 | Medtronic, Inc. | Lithium battery manufacturing method |
US8547248B2 (en) | 2005-09-01 | 2013-10-01 | Proteus Digital Health, Inc. | Implantable zero-wire communications system |
US8836513B2 (en) | 2006-04-28 | 2014-09-16 | Proteus Digital Health, Inc. | Communication system incorporated in an ingestible product |
US8956287B2 (en) | 2006-05-02 | 2015-02-17 | Proteus Digital Health, Inc. | Patient customized therapeutic regimens |
US11928614B2 (en) | 2006-05-02 | 2024-03-12 | Otsuka Pharmaceutical Co., Ltd. | Patient customized therapeutic regimens |
US8054140B2 (en) | 2006-10-17 | 2011-11-08 | Proteus Biomedical, Inc. | Low voltage oscillator for medical devices |
WO2008052136A3 (en) * | 2006-10-25 | 2008-10-23 | Proteus Biomedical Inc | Controlled activation ingestible identifier |
US11357730B2 (en) | 2006-10-25 | 2022-06-14 | Otsuka Pharmaceutical Co., Ltd. | Controlled activation ingestible identifier |
US10238604B2 (en) | 2006-10-25 | 2019-03-26 | Proteus Digital Health, Inc. | Controlled activation ingestible identifier |
US8945005B2 (en) | 2006-10-25 | 2015-02-03 | Proteus Digital Health, Inc. | Controlled activation ingestible identifier |
US9444503B2 (en) | 2006-11-20 | 2016-09-13 | Proteus Digital Health, Inc. | Active signal processing personal health signal receivers |
US8718193B2 (en) | 2006-11-20 | 2014-05-06 | Proteus Digital Health, Inc. | Active signal processing personal health signal receivers |
US9083589B2 (en) | 2006-11-20 | 2015-07-14 | Proteus Digital Health, Inc. | Active signal processing personal health signal receivers |
US10441194B2 (en) | 2007-02-01 | 2019-10-15 | Proteus Digital Heal Th, Inc. | Ingestible event marker systems |
US8858432B2 (en) | 2007-02-01 | 2014-10-14 | Proteus Digital Health, Inc. | Ingestible event marker systems |
US8956288B2 (en) | 2007-02-14 | 2015-02-17 | Proteus Digital Health, Inc. | In-body power source having high surface area electrode |
US11464423B2 (en) | 2007-02-14 | 2022-10-11 | Otsuka Pharmaceutical Co., Ltd. | In-body power source having high surface area electrode |
US9270025B2 (en) | 2007-03-09 | 2016-02-23 | Proteus Digital Health, Inc. | In-body device having deployable antenna |
US8932221B2 (en) | 2007-03-09 | 2015-01-13 | Proteus Digital Health, Inc. | In-body device having a multi-directional transmitter |
US8540632B2 (en) | 2007-05-24 | 2013-09-24 | Proteus Digital Health, Inc. | Low profile antenna for in body device |
US8115618B2 (en) | 2007-05-24 | 2012-02-14 | Proteus Biomedical, Inc. | RFID antenna for in-body device |
US10517506B2 (en) | 2007-05-24 | 2019-12-31 | Proteus Digital Health, Inc. | Low profile antenna for in body device |
US8961412B2 (en) | 2007-09-25 | 2015-02-24 | Proteus Digital Health, Inc. | In-body device with virtual dipole signal amplification |
US9433371B2 (en) | 2007-09-25 | 2016-09-06 | Proteus Digital Health, Inc. | In-body device with virtual dipole signal amplification |
US11612321B2 (en) | 2007-11-27 | 2023-03-28 | Otsuka Pharmaceutical Co., Ltd. | Transbody communication systems employing communication channels |
US20090181298A1 (en) * | 2008-01-10 | 2009-07-16 | Eaglepicher Energy Products Corporation | Integral electrochemical device |
US20090202899A1 (en) * | 2008-02-11 | 2009-08-13 | Pyszczek Michael F | Electrical apparatus with integral thin film solid state battery and methods of manufacture |
US9060708B2 (en) | 2008-03-05 | 2015-06-23 | Proteus Digital Health, Inc. | Multi-mode communication ingestible event markers and systems, and methods of using the same |
US8542123B2 (en) | 2008-03-05 | 2013-09-24 | Proteus Digital Health, Inc. | Multi-mode communication ingestible event markers and systems, and methods of using the same |
US8258962B2 (en) | 2008-03-05 | 2012-09-04 | Proteus Biomedical, Inc. | Multi-mode communication ingestible event markers and systems, and methods of using the same |
US8810409B2 (en) | 2008-03-05 | 2014-08-19 | Proteus Digital Health, Inc. | Multi-mode communication ingestible event markers and systems, and methods of using the same |
US9258035B2 (en) | 2008-03-05 | 2016-02-09 | Proteus Digital Health, Inc. | Multi-mode communication ingestible event markers and systems, and methods of using the same |
US9603550B2 (en) | 2008-07-08 | 2017-03-28 | Proteus Digital Health, Inc. | State characterization based on multi-variate data fusion techniques |
US11217342B2 (en) | 2008-07-08 | 2022-01-04 | Otsuka Pharmaceutical Co., Ltd. | Ingestible event marker data framework |
US10682071B2 (en) | 2008-07-08 | 2020-06-16 | Proteus Digital Health, Inc. | State characterization based on multi-variate data fusion techniques |
US9415010B2 (en) | 2008-08-13 | 2016-08-16 | Proteus Digital Health, Inc. | Ingestible circuitry |
US8540633B2 (en) | 2008-08-13 | 2013-09-24 | Proteus Digital Health, Inc. | Identifier circuits for generating unique identifiable indicators and techniques for producing same |
US8721540B2 (en) | 2008-08-13 | 2014-05-13 | Proteus Digital Health, Inc. | Ingestible circuitry |
US8036748B2 (en) | 2008-11-13 | 2011-10-11 | Proteus Biomedical, Inc. | Ingestible therapy activator system and method |
US8055334B2 (en) | 2008-12-11 | 2011-11-08 | Proteus Biomedical, Inc. | Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same |
US8583227B2 (en) | 2008-12-11 | 2013-11-12 | Proteus Digital Health, Inc. | Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same |
US8545436B2 (en) | 2008-12-15 | 2013-10-01 | Proteus Digital Health, Inc. | Body-associated receiver and method |
US9659423B2 (en) | 2008-12-15 | 2017-05-23 | Proteus Digital Health, Inc. | Personal authentication apparatus system and method |
US9439566B2 (en) | 2008-12-15 | 2016-09-13 | Proteus Digital Health, Inc. | Re-wearable wireless device |
US9149577B2 (en) | 2008-12-15 | 2015-10-06 | Proteus Digital Health, Inc. | Body-associated receiver and method |
US8114021B2 (en) | 2008-12-15 | 2012-02-14 | Proteus Biomedical, Inc. | Body-associated receiver and method |
US9883819B2 (en) | 2009-01-06 | 2018-02-06 | Proteus Digital Health, Inc. | Ingestion-related biofeedback and personalized medical therapy method and system |
US8597186B2 (en) | 2009-01-06 | 2013-12-03 | Proteus Digital Health, Inc. | Pharmaceutical dosages delivery system |
US8540664B2 (en) | 2009-03-25 | 2013-09-24 | Proteus Digital Health, Inc. | Probablistic pharmacokinetic and pharmacodynamic modeling |
US9119918B2 (en) | 2009-03-25 | 2015-09-01 | Proteus Digital Health, Inc. | Probablistic pharmacokinetic and pharmacodynamic modeling |
US9320455B2 (en) | 2009-04-28 | 2016-04-26 | Proteus Digital Health, Inc. | Highly reliable ingestible event markers and methods for using the same |
US10588544B2 (en) | 2009-04-28 | 2020-03-17 | Proteus Digital Health, Inc. | Highly reliable ingestible event markers and methods for using the same |
US8545402B2 (en) | 2009-04-28 | 2013-10-01 | Proteus Digital Health, Inc. | Highly reliable ingestible event markers and methods for using the same |
US9149423B2 (en) | 2009-05-12 | 2015-10-06 | Proteus Digital Health, Inc. | Ingestible event markers comprising an ingestible component |
US8558563B2 (en) | 2009-08-21 | 2013-10-15 | Proteus Digital Health, Inc. | Apparatus and method for measuring biochemical parameters |
US9941931B2 (en) | 2009-11-04 | 2018-04-10 | Proteus Digital Health, Inc. | System for supply chain management |
US8868453B2 (en) | 2009-11-04 | 2014-10-21 | Proteus Digital Health, Inc. | System for supply chain management |
US10305544B2 (en) | 2009-11-04 | 2019-05-28 | Proteus Digital Health, Inc. | System for supply chain management |
US8784308B2 (en) | 2009-12-02 | 2014-07-22 | Proteus Digital Health, Inc. | Integrated ingestible event marker system with pharmaceutical product |
US10376218B2 (en) | 2010-02-01 | 2019-08-13 | Proteus Digital Health, Inc. | Data gathering system |
US9014779B2 (en) | 2010-02-01 | 2015-04-21 | Proteus Digital Health, Inc. | Data gathering system |
US11173290B2 (en) | 2010-04-07 | 2021-11-16 | Otsuka Pharmaceutical Co., Ltd. | Miniature ingestible device |
US10207093B2 (en) | 2010-04-07 | 2019-02-19 | Proteus Digital Health, Inc. | Miniature ingestible device |
US9597487B2 (en) | 2010-04-07 | 2017-03-21 | Proteus Digital Health, Inc. | Miniature ingestible device |
US10529044B2 (en) | 2010-05-19 | 2020-01-07 | Proteus Digital Health, Inc. | Tracking and delivery confirmation of pharmaceutical products |
US9044316B2 (en) | 2010-09-07 | 2015-06-02 | Elenza, Inc. | Installation and sealing of a battery on a thin glass wafer to supply power to an intraocular implant |
WO2012033752A1 (en) * | 2010-09-07 | 2012-03-15 | Elenza, Inc. | Installation and sealing of a battery on a thin glass wafer to supply power to an intraocular implant |
US9107806B2 (en) | 2010-11-22 | 2015-08-18 | Proteus Digital Health, Inc. | Ingestible device with pharmaceutical product |
US11504511B2 (en) | 2010-11-22 | 2022-11-22 | Otsuka Pharmaceutical Co., Ltd. | Ingestible device with pharmaceutical product |
US9439599B2 (en) | 2011-03-11 | 2016-09-13 | Proteus Digital Health, Inc. | Wearable personal body associated device with various physical configurations |
US9756874B2 (en) | 2011-07-11 | 2017-09-12 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
US11229378B2 (en) | 2011-07-11 | 2022-01-25 | Otsuka Pharmaceutical Co., Ltd. | Communication system with enhanced partial power source and method of manufacturing same |
US10223905B2 (en) | 2011-07-21 | 2019-03-05 | Proteus Digital Health, Inc. | Mobile device and system for detection and communication of information received from an ingestible device |
US9235683B2 (en) | 2011-11-09 | 2016-01-12 | Proteus Digital Health, Inc. | Apparatus, system, and method for managing adherence to a regimen |
US9271897B2 (en) | 2012-07-23 | 2016-03-01 | Proteus Digital Health, Inc. | Techniques for manufacturing ingestible event markers comprising an ingestible component |
US9268909B2 (en) | 2012-10-18 | 2016-02-23 | Proteus Digital Health, Inc. | Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device |
US11149123B2 (en) | 2013-01-29 | 2021-10-19 | Otsuka Pharmaceutical Co., Ltd. | Highly-swellable polymeric films and compositions comprising the same |
US11744481B2 (en) | 2013-03-15 | 2023-09-05 | Otsuka Pharmaceutical Co., Ltd. | System, apparatus and methods for data collection and assessing outcomes |
US11741771B2 (en) | 2013-03-15 | 2023-08-29 | Otsuka Pharmaceutical Co., Ltd. | Personal authentication apparatus system and method |
US10175376B2 (en) | 2013-03-15 | 2019-01-08 | Proteus Digital Health, Inc. | Metal detector apparatus, system, and method |
US11158149B2 (en) | 2013-03-15 | 2021-10-26 | Otsuka Pharmaceutical Co., Ltd. | Personal authentication apparatus system and method |
US9796576B2 (en) | 2013-08-30 | 2017-10-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
US10421658B2 (en) | 2013-08-30 | 2019-09-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
US9270503B2 (en) | 2013-09-20 | 2016-02-23 | Proteus Digital Health, Inc. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
US10097388B2 (en) | 2013-09-20 | 2018-10-09 | Proteus Digital Health, Inc. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
US11102038B2 (en) | 2013-09-20 | 2021-08-24 | Otsuka Pharmaceutical Co., Ltd. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
US9787511B2 (en) | 2013-09-20 | 2017-10-10 | Proteus Digital Health, Inc. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
US10498572B2 (en) | 2013-09-20 | 2019-12-03 | Proteus Digital Health, Inc. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
US9577864B2 (en) | 2013-09-24 | 2017-02-21 | Proteus Digital Health, Inc. | Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance |
US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
US10398161B2 (en) | 2014-01-21 | 2019-09-03 | Proteus Digital Heal Th, Inc. | Masticable ingestible product and communication system therefor |
US11051543B2 (en) | 2015-07-21 | 2021-07-06 | Otsuka Pharmaceutical Co. Ltd. | Alginate on adhesive bilayer laminate film |
US10797758B2 (en) | 2016-07-22 | 2020-10-06 | Proteus Digital Health, Inc. | Electromagnetic sensing and detection of ingestible event markers |
US10187121B2 (en) | 2016-07-22 | 2019-01-22 | Proteus Digital Health, Inc. | Electromagnetic sensing and detection of ingestible event markers |
US11529071B2 (en) | 2016-10-26 | 2022-12-20 | Otsuka Pharmaceutical Co., Ltd. | Methods for manufacturing capsules with ingestible event markers |
US11793419B2 (en) | 2016-10-26 | 2023-10-24 | Otsuka Pharmaceutical Co., Ltd. | Methods for manufacturing capsules with ingestible event markers |
US11950615B2 (en) | 2021-11-10 | 2024-04-09 | Otsuka Pharmaceutical Co., Ltd. | Masticable ingestible product and communication system therefor |
Also Published As
Publication number | Publication date |
---|---|
WO2002087697A3 (en) | 2003-08-21 |
US6782290B2 (en) | 2004-08-24 |
US20020161404A1 (en) | 2002-10-31 |
WO2002087697A2 (en) | 2002-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6782290B2 (en) | Implantable medical device with rechargeable thin-film microbattery power source | |
US7531010B1 (en) | Design for capacitor anode assembly | |
US20070150020A1 (en) | Externally oriented battery feedthrough with integral connector | |
EP0707351B1 (en) | Rebalancing of lithium/silver vanadium oxide (LI/SVO) cells | |
US7196899B1 (en) | Capacitor anode assembly | |
US8771861B2 (en) | Secondary battery and method for manufacturing the same | |
JP4440850B2 (en) | Secondary battery | |
KR100496305B1 (en) | Pouched-type lithium secondary battery and the fabrication method thereof | |
EP1042827B1 (en) | A composite battery and methods of forming same | |
US6805719B2 (en) | Balanced anode electrode | |
US7893659B2 (en) | Method and apparatus for amplitude limiting battery temperature spikes | |
US8055346B2 (en) | Implantable pulse generator with a stacked battery and capacitor | |
WO2003061038A1 (en) | Electric storage battery construction and method of manufacture | |
JPH04366547A (en) | Gas depolarizing assembling battery | |
KR100408140B1 (en) | Cell and cell inspecting method | |
US5821006A (en) | Hybrid cell/capacitor assembly for use in a battery pack | |
CA2290714C (en) | Battery box | |
KR20180107461A (en) | Process of Manufacturing Battery Cell Having Auxiliary Sealing Part for Preventing Crack of Battery Case | |
JP2019514580A (en) | Control of lithium cluster growth of battery | |
CN1423360A (en) | Method for making secondary cell | |
US20040064163A1 (en) | Contoured battery for implantable medical devices and method of manufacture | |
JP2005079080A (en) | Thin battery pack | |
CN103794740A (en) | Electrochemical device | |
KR20040107868A (en) | Pouched-type lithium secondary battery | |
KR20190069044A (en) | Battery module and battery pack including the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |